Browse by Speaker

Type here to filter the list

A
Abbasi, Ammal

University of California San Diego
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Ammal Abbasi
Favorite
Abdul Razak, Albiruni Ryan

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto; Department of Medical Oncology, Mount Sinai Hospital
Session 3: Medical & Pediatric Oncology and Clinical Trials
Location: VCC, East Exhibition Hall A
Albiruni Ryan Abdul Razak
Favorite
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Albiruni Ryan Abdul Razak
Favorite
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Albiruni Ryan Abdul Razak
Favorite
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Albiruni Ryan Abdul Razak
Favorite
Acidi, Belkacem

Gustave Roussy
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Belkacem Acidi
Favorite
Adams, M.

Department of Paediatric Oncology, Children's Hospital for Wales, University Hospital
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
M. Adams
Favorite
Aggenbach, Laura

The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Laura Aggenbach
Favorite
Aguiar, Jr, Samuel

TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Samuel Aguiar, Jr
Favorite
Agulnik, Mark

City of Hope Comprehensive Cancer Center
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Mark Agulnik
Favorite
Ahmed, Safia

Mayo Clinic
Paper 39 - PENCIL BEAM SCANNING PROTON RADIOTHERAPY FOR SACRAL CHORDOMAS: THE MAYO CLINIC EXPERIENCE
Safia Ahmed
Favorite
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Safia Ahmed
Favorite
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Safia Ahmed
Favorite
Ajayi, Dolapo

University College London Cancer Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Dolapo Ajayi
Favorite
Ajuyah, Pamela

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Pamela Ajuyah
Favorite
Akdemir, Kadir

MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Kadir Akdemir
Favorite
Albers, Joachim

The healthcare business of Merck KGaA, Darmstadt, Germany
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Joachim Albers
Favorite
Albert, Catherine

Seattle Children’s Hospital, University of Washington, Fred Hutchinson Cancer Research Center
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Catherine Albert
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Catherine Albert
Favorite
Albertsmeier, Markus

Ludwig-Maximilians-Universität, University Hospital
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Markus Albertsmeier
Favorite
Alcindor, Thierry

Dana-Farber Cancer Institute
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Thierry Alcindor
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Thierry Alcindor
Favorite
Alexander, Sandy

Moffitt
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Sandy Alexander
Favorite
Alexandrov, Ludmil

University of California San Diego
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Ludmil Alexandrov
Favorite
Algarra, Salvador

Clínica Universidad de Navarra
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Salvador Algarra
Favorite
Aliaga, Alfonso

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Alfonso Aliaga
Favorite
Al-Ibraheemi, Alyaa

Department of Pathology, Boston Children’s Hospital
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Alyaa Al-Ibraheemi
Favorite
Allen-Rhoades, Wendy

Mayo Clinic
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Wendy Allen-Rhoades
Favorite
Allis, C. David

The Rockefeller University
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
C. David Allis
Favorite
Al-Mukhtar, Ahmed

Sheffield Teaching Hospital NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Ahmed Al-Mukhtar
Favorite
Alvarez-Breckenridge, Christopher

MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Christopher Alvarez-Breckenridge
Favorite
Amini, Behrang

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Behrang Amini
Favorite
Anderson, Peter

Cleveland Clinic Children's
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Peter Anderson
Favorite
Andrulis, Irene

Mount Sinai Hospital
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Irene Andrulis
Favorite
Annareddy, Thejo

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Thejo Annareddy
Favorite
Anton, Leah

Sylvester Comprehensive Cancer Center, University of Miami
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Leah Anton
Favorite
Araujo, Dejka M.

The University of Texas MD Anderson Cancer Center
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Dejka M. Araujo
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Dejka M. Araujo
Favorite
Armstrong, Samantha

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Samantha Armstrong
Favorite
Arshad, Junaid

University of Arizona Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Junaid Arshad
Favorite
Arvis, Pierre

Bayer Pharmaceuticals
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Pierre Arvis
Favorite
Atkinson, Thomas

Memorial Sloan Kettering Cancer Center
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Thomas Atkinson
Favorite
Attia, Steven

Mayo Clinic
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Steven Attia
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Steven Attia
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Steven Attia
Favorite
Augustin, Yolanda

Royal Marsden NHS Foundation Trust
Paper 40 - PRIMARY CARDIAC AND GREAT VESSEL SARCOMAS: MULTI-MODALITY MANAGEMENT AND CLINICAL OUTCOMES AT THE ROYAL MARSDEN HOSPITAL 1987-2021
Yolanda Augustin
Favorite
Avedian, Raffi

Stanford University
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Raffi Avedian
Favorite
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Raffi Avedian
Favorite
Avutu, Viswatej

Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Viswatej Avutu
Favorite
Ayre, Gareth

University Hospitals Bristol NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Gareth Ayre
Favorite
Azad, Nilofer

Johns Hopkins Sidney Kimmel Cancer Center
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Nilofer Azad
Favorite
B
Babichev, Yael

Lunenfeld Tanenbaum Research Institute
Paper 32 - ESTABLISHMENT OF HIGH-GRADE SOFT TISSUE SARCOMA METASTATIC DISEASE MURINE MODELS
Yael Babichev
Favorite
BAHRI, Haifa

Leon Berard center
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Haifa BAHRI
Favorite
Bailey, Kelly

Department of Pediatrics, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Kelly Bailey
Favorite
Bailey, Nathanael

Department of Pathology, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Nathanael Bailey
Favorite
Baird, John

PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
John Baird
Favorite
Bajpai, Jyoti

Tata Memorial Centre
Session 13: Epidemiology, Informatics, Population Health, Health Outcomes
Location: VCC, East Exhibition Hall A
Jyoti Bajpai
Favorite
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Jyoti Bajpai
Favorite
Baker, Laurence H.

Michigan Medicine, University of Michigan
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Laurence H. Baker
Favorite
Balaguer Román, Andrés

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Andrés Balaguer Román
Favorite
Ballman, Karla

Weill Cornell
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Karla Ballman
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Karla Ballman
Favorite
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Karla Ballman
Favorite
Banavali, Shripad

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Shripad Banavali
Favorite
Bandula, Steve

University College Hospital London NHS Foundation Trust
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Steve Bandula
Favorite
Barahona, Paulette

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Paulette Barahona
Favorite
Bardgett, Michelle

Newcastle University
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Michelle Bardgett
Favorite
Barger, Zara

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Zara Barger
Favorite
Barisella, Marta

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Marta Barisella
Favorite
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Marta Barisella
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Marta Barisella
Favorite
Barlow, Adam

Leeds Teaching Hospitals NHS Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Adam Barlow
Favorite
Barnett, Reagan

Guardant Health
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Reagan Barnett
Favorite
Barreto-Coelho, Priscila

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Priscila Barreto-Coelho
Favorite
Barretta, Francesco

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Francesco Barretta
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Francesco Barretta
Favorite
Barrows, Douglas

The Rockefeller University
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Douglas Barrows
Favorite
Batrakou, Dzmitry

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Dzmitry Batrakou
Favorite
Baucco, Patricia

Cleveland Clinic Children's
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Patricia Baucco
Favorite
Bauer, Sebastian

Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen and German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany
Mentorship Session 1: How to Set Up Clinical Trials
Sebastian Bauer
Favorite
Session 14: Bone Sarcomas
Location: VCC, East Exhibition Hall A
Sebastian Bauer
Favorite
Session 4: Preclinical Models & Translational Research
Location: VCC, East Exhibition Hall A
Sebastian Bauer
Favorite
Session 7: GIST & Other Sarcomas with Actionable Targets
Location: VCC, East Exhibition Hall A
Sebastian Bauer
Favorite
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Sebastian Bauer
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Sebastian Bauer
Favorite
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Sebastian Bauer
Favorite
Bauer, Todd M.

Sarah Cannon Research Institute, Tennessee Oncology
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Todd M. Bauer
Favorite
Bayanjargal, Ariunaa

nationwide childrens hospital
Paper 95 - STUDYING THE ROLE OF FLI PORTION OF EWS: FLI IN TRANSCRIPTION REGULATION VIA MODULATION OF CHROMATIN 3D LANDSCAPE IN EWING SARCOMA
Ariunaa Bayanjargal
Favorite
Bedi, Meena

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Meena Bedi
Favorite
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
Meena Bedi
Favorite
Been, Lukas B.

Department of Surgical Oncology, University Medical Center Groningen, University of Groningen
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Lukas B. Been
Favorite
Beird, Hannah

MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Hannah Beird
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Hannah Beird
Favorite
Bell, Timothy

SpringWorks Therapeutics
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Timothy Bell
Favorite
Bender, Lewis

Intensity Therapeutics
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Lewis Bender
Favorite
Benjamin, Robert

The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Robert Benjamin
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Robert Benjamin
Favorite
Benson, Charlotte

The Royal Marsden NHS Foundation Trust
Paper 40 - PRIMARY CARDIAC AND GREAT VESSEL SARCOMAS: MULTI-MODALITY MANAGEMENT AND CLINICAL OUTCOMES AT THE ROYAL MARSDEN HOSPITAL 1987-2021
Charlotte Benson
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Charlotte Benson
Favorite
Bernthal, Nicholas

David Geffen School of Medicine at UCLA, Santa Monica, CA, USA
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Nicholas Bernthal
Favorite
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Nicholas Bernthal
Favorite
Bertolotti, Alessia

Fondazion IRCCS Istituto Nazionale Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Alessia Bertolotti
Favorite
Bhargava, Prabhat

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Prabhat Bhargava
Favorite
Bialick, Steven

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Steven Bialick
Favorite
Binitie, Odion

Moffitt Cancer Center
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Odion Binitie
Favorite
Biondi, Nicola

Precision Sarcoma Research Group, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Nicola Biondi
Favorite
Bird, Justin

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Justin Bird
Favorite
Birkett, Lauren

Teenage Young Adult AC Unit, University College Hospital MacMillan Centre, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Lauren Birkett
Favorite
Biswas, Swethajit

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Swethajit Biswas
Favorite
Blackwell, Lauren

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Lauren Blackwell
Favorite
Blank, Alan

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Alan Blank
Favorite
Blattmann, Claudia

Olgahospital
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Claudia Blattmann
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Claudia Blattmann
Favorite
Blay, Jean-Yves

Centre Léon Bérard and Université Claude Bernard, Lyon, France
Debate on Genomics: Should Patients with Sarcoma Have Next Generation Sequencing Performed at the Time of Diagnosis?
Location: VCC, East Exhibition Hall A
Jean-Yves Blay
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Jean-Yves Blay
Favorite
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Jean-Yves Blay
Favorite
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Jean-Yves Blay
Favorite
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Jean-Yves Blay
Favorite
Blazer, Dan

Duke University Medical Center
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Dan Blazer
Favorite
Bodlak, Avery

Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Avery Bodlak
Favorite
Boecxstaens, Veerle

Universitair Ziekenhuis Leuven
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Veerle Boecxstaens
Favorite
Boegseth, Hilde

Oslo University Hospital
Paper 53 - THERE’S NO PLACE LIKE HOME. TREATING ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA AT HOME
Hilde Boegseth
Favorite
Bollard, Julien

Research and Innovation, Centre Léon Bérard
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Julien Bollard
Favorite
Bonenkamp, Han

Radboud University Medical Center
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Han Bonenkamp
Favorite
Bonvalot, Sylvie

Institut Curie - Paris, FRANCE
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Sylvie Bonvalot
Favorite
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Sylvie Bonvalot
Favorite
Bordogna, Walter

F. Hoffmann-La Roche Ltd
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Walter Bordogna
Favorite
Bouhamama, Amine

CENTRE LEON BERARD
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Amine Bouhamama
Favorite
Bovee, J.V.M.G.

Department of Pathology, Leiden University Medical Center
Session 4: Preclinical Models & Translational Research
Location: VCC, East Exhibition Hall A
J.V.M.G. Bovee
Favorite
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
J.V.M.G. Bovee
Favorite
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
J.V.M.G. Bovee
Favorite
Bowes, Amy

Francis Crick Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Amy Bowes
Favorite
Boye, Kjetil

Oslo University Hospital
Mentorship Session 5: Setting Up Collaborations in Rare Tumors
Kjetil Boye
Favorite
Paper 53 - THERE’S NO PLACE LIKE HOME. TREATING ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA AT HOME
Kjetil Boye
Favorite
Brahmi, Medhi

centre leon Berard
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Medhi Brahmi
Favorite
Brahmi, Mehdi

Department of Medical Oncology, Centre Léon Bérard,
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Mehdi Brahmi
Favorite
Braire-deBruijn, Inge

Department of Pathology, Leiden University Medical Center, Leiden
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Inge Braire-deBruijn
Favorite
Brar, Savtaj

Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Savtaj Brar
Favorite
Braunstein, Steve

University of California San Francisco
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Steve Braunstein
Favorite
Brich, Silvia

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Silvia Brich
Favorite
Brien, Earl

Cedars-Sinai Medical Center
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Earl Brien
Favorite
Briggs, Christopher

University Hospital Plymouth NHS Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Christopher Briggs
Favorite
Broad, Robyn

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Robyn Broad
Favorite
Broida, Samuel

Mayo Clinic
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Samuel Broida
Favorite
Brookes, Marcus

The Newcastle upon Tyne Hospitals NHS Foundation Trust
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Marcus Brookes
Favorite
Brors, Benedikt

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Benedikt Brors
Favorite
Brown, Jeffrey

University of Miami Miller School of Medicine
Paper 74 - TOTAL SIZE OF POST-OPERATIVE SEROMA CORRELATES WITH WOUND COMPLICATIONS FOLLOWING SOFT-TISSUE SARCOMA RESECTION
Jeffrey Brown
Favorite
Brown, Joel

Moffitt
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Joel Brown
Favorite
Brown, Lauren

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Lauren Brown
Favorite
Brunello, Antonella

Veneto Institute of Oncology IOV – IRCCS
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Antonella Brunello
Favorite
Bruno, Tullia

Department of Immunology, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Tullia Bruno
Favorite
Bryce, Richard

Rain Therapeutics, Inc.
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Richard Bryce
Favorite
Buac, Neil

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Neil Buac
Favorite
Budd, George

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
George Budd
Favorite
Bui, Marilyn M

Department of Pathology, Moffitt Cancer Center & Research Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Marilyn M Bui
Favorite
Bui, Nam

Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Nam Bui
Favorite
Bullock, Andrea

Beth Israel Deaconess Medical Center
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Andrea Bullock
Favorite
Bullock, Bonnie

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Bonnie Bullock
Favorite
Burgess, Melissa

University of Pittsburgh
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Melissa Burgess
Favorite
Burke, Zachary

University of Toronto
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Zachary Burke
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Zachary Burke
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Zachary Burke
Favorite
Burt, Alistair

The Newcastle upon Tyne NHS Hospitals Foundation Trust
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Alistair Burt
Favorite
Buxton, Allen

Children's Oncology Group
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Allen Buxton
Favorite
C
Cahill, Ronan

University College Dublin
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Ronan Cahill
Favorite
Callan, Alexandra

UT Southwestern
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Alexandra Callan
Favorite
Callegaro, Dario

Fondazione IRCCS Istituto Nazionale dei Tumori
Session 1: Telemedicine, Virtual Tumor Boards and Multidisciplinary Care
Location: VCC, East Exhibition Hall A
Dario Callegaro
Favorite
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Dario Callegaro
Favorite
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Dario Callegaro
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Dario Callegaro
Favorite
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Dario Callegaro
Favorite
Calleja, Michele

Royal National Orthopaedic Hospital NHS Trust
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Michele Calleja
Favorite
Camacho, Luis

Center for Oncology and Blood Disorders
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Luis Camacho
Favorite
Cam, Maren

Center for Childhood Cancer, Nationwide Children's Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Maren Cam
Favorite
Campoverde, Leticia

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Leticia Campoverde
Favorite
Cannon, Matthew

Center for Childhood Cancer, Nationwide Children's Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Matthew Cannon
Favorite
Cardona, Diana

Duke University
Paper 30 - SUCCESS AND CHALLENGES OF GENERATING A GENETICALLY ENGINEERED MOUSE MODEL OF CIC-DUX4 SARCOMA
Diana Cardona
Favorite
Cardona, Kenneth

Winship Cancer Institute, Emory University
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Kenneth Cardona
Favorite
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Kenneth Cardona
Favorite
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
Kenneth Cardona
Favorite
Carter, Allie

Indiana University Department of Biostatistics and Health Data Science
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Allie Carter
Favorite
Casali, Paolo

University of Milan
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Paolo Casali
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Paolo Casali
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Paolo Casali
Favorite
Catton, Charles

Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Charles Catton
Favorite
Cayuela Fuentes, Valentín

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Valentín Cayuela Fuentes
Favorite
Cerda-Smith, Christian

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Christian Cerda-Smith
Favorite
Cerezuela Fernández de Palencia, Álvaro

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Álvaro Cerezuela Fernández de Palencia
Favorite
Chan, Corey

Newcastle University Translational and Clinical Research Institute
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Corey Chan
Favorite
Chan, Jason

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Jason Chan
Favorite
Charlson, John

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
John Charlson
Favorite
Charon, V.

CHU Rennes, Radiology Department, F-35033
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
V. Charon
Favorite
Charville, Gregory

Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Gregory Charville
Favorite
Chatziantoniou, C.

Image Science Institute, UMC Utrecht
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
C. Chatziantoniou
Favorite
Chatzipli, Aikaterini

Department of Biomedical Informatics, Harvard Medical School
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Aikaterini Chatzipli
Favorite
Chawla, Sant

Sarcoma Oncology Research Center
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Sant Chawla
Favorite
Chen, Helen

National Cancer Institute
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Helen Chen
Favorite
Cherlin, Svetlana

Newcastle University
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Svetlana Cherlin
Favorite
Chiang, Yi-Ju

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Yi-Ju Chiang
Favorite
Chibon, Frederic

8. OncoSarc, INSERM U1037, Cancer Research Center in Toulouse and Department of Pathology, Institut Claudius Régaud, IUCT-Oncopole,
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Frederic Chibon
Favorite
Childress, Jason

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Jason Childress
Favorite
Chinnaswamy, Girish

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Girish Chinnaswamy
Favorite
Chi, Ping

Memorial Sloan Kettering Cancer Center
Mentorship Session 2: How to Grant Write
Ping Chi
Favorite
Session 7: GIST & Other Sarcomas with Actionable Targets
Location: VCC, East Exhibition Hall A
Ping Chi
Favorite
Cho, Soo-Jin

University of California San Francisco
Paper 04 - DIGITAL PATHOLOGY IN SARCOMA MANAGEMENT, A SINGLE INSTITUTION PERSPECTIVE
Soo-Jin Cho
Favorite
Choy, Edwin

Massachusetts General Hospital
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Edwin Choy
Favorite
Christ, Alexander

Children's Hospital Los Angeles
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Alexander Christ
Favorite
Chuba, Paul

Ascension
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Paul Chuba
Favorite
Chudasama, Priya

Precision Sarcoma Research Group, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg
Session 2: Sarcoma Biology & 'omics
Location: VCC, East Exhibition Hall A
Priya Chudasama
Favorite
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Priya Chudasama
Favorite
Chugh, Rashmi

University of Michigan
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Rashmi Chugh
Favorite
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Rashmi Chugh
Favorite
Chung, Christine

Moffitt
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Christine Chung
Favorite
Chung, Peter

Department of Radiation Oncology, Princess Margaret Centre, University of Toronto
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Peter Chung
Favorite
Cichowski, Karen

Brigham and Women's Hospital
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Karen Cichowski
Favorite
Coker, David

The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
David Coker
Favorite
Colburg, Deana

Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Deana Colburg
Favorite
Cole, Hunter

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Hunter Cole
Favorite
Collier, Christopher

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Christopher Collier
Favorite
Collini, Paola

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Paola Collini
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Paola Collini
Favorite
Collins, Natalie

Dana Farber Cancer Institute
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Natalie Collins
Favorite
Colman, Matthew

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Matthew Colman
Favorite
Colombo, Chiara

Fondazione IRCCS Istituto Nazionale dei Tumori
Session 12: Desmoid Fibromatosis
Location: VCC, East Exhibition Hall A
Chiara Colombo
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Chiara Colombo
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Chiara Colombo
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Chiara Colombo
Favorite
Colwell, Bruce

QEII Cancer Centre
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Bruce Colwell
Favorite
Coma, A.

Pediatric Radiology Department. Vall d'Hebron Hospital
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
A. Coma
Favorite
Conley, Anthony

MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Anthony Conley
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Anthony Conley
Favorite
Corina, Kim-Fuchs

Inselspital, Bern University Hospital
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Kim-Fuchs Corina
Favorite
Corradini, Nadège

IHOPe
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Nadège Corradini
Favorite
Cortes-Ciriano, Isidro

European Molecular Biology Laboratory, European Bioinformatics Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Isidro Cortes-Ciriano
Favorite
Cosker, Thomas

Oxford University Hospital NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Thomas Cosker
Favorite
Costa, Philippos

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Philippos Costa
Favorite
Counter, Christopher

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Christopher Counter
Favorite
Coward*, Victoria

Lunenfeld-Tanenbaum Research Institute
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Victoria Coward*
Favorite
Cowley, Mark

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Mark Cowley
Favorite
Crompton, Joseph

UCLA Health
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Joseph Crompton
Favorite
Crow, Jesse C

Forge
Paper 95 - STUDYING THE ROLE OF FLI PORTION OF EWS: FLI IN TRANSCRIPTION REGULATION VIA MODULATION OF CHROMATIN 3D LANDSCAPE IN EWING SARCOMA
Jesse C Crow
Favorite
Cuglievan, Branko

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Branko Cuglievan
Favorite
D
Dabas, Yakshi

The Rockefeller University
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Yakshi Dabas
Favorite
Dai, Dong

Daiichi Sankyo, Inc.
Paper 87 - PATIENT-REPORTED SYMPTOM IMPROVEMENT IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR: A CROSS-SECTIONAL SURVEY IN THE UNITED STATES
Dong Dai
Favorite
Daley, Jessica

University of Pittsburgh, UPMC Children's Hospital of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Jessica Daley
Favorite
Daly, Roger

Monash University
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Roger Daly
Favorite
D'Amato, Gina

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Gina D'Amato
Favorite
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Gina D'Amato
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Gina D'Amato
Favorite
Dang, Alexa

BC Cancer
Paper 38 - PATIENT OUTCOMES IN METASTATIC EWING SARCOMA RESTRICTED TO PULMONARY METASTASES TREATED WITH WHOLE LUNG RADIATION
Alexa Dang
Favorite
D'Angelo, Sandra

Memorial Sloan Kettering Cancer Center
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Sandra D'Angelo
Favorite
Daskalopoulou, Christina

IQVIA
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Christina Daskalopoulou
Favorite
Davies, Emma

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Emma Davies
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Emma Davies
Favorite
Davis, Elizabeth

Vanderbilt University Medical Center
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Elizabeth Davis
Favorite
Davis, Korbin

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Korbin Davis
Favorite
Davis, Lara

Oregon Health & Science University
Adolescent & Young Adult: Poster Highlights
Lara Davis
Favorite
Session 8: Adolescent & Young Adult Sarcoma
Location: VCC, East Exhibition Hall A
Lara Davis
Favorite
Daw, Najat

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Najat Daw
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Najat Daw
Favorite
De Cecco, Loris

Fondazione IRCCS Istituto Nazionale Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Loris De Cecco
Favorite
De Cock, Lore

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Lore De Cock
Favorite
de Donno, G.

Image Science Institute, UMC Utrecht
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
G. de Donno
Favorite
De La Cuesta, Esther

Bayer HealthCare Pharmaceuticals, Inc.
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Esther De La Cuesta
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Esther De La Cuesta
Favorite
de Luca, Alberto

Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands; Neurology Department, UMC Utrecht Brain Center, University Medical Center Utrecht
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Alberto de Luca
Favorite
de Miranda, Noel

Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Noel de Miranda
Favorite
De Sutter, Luna

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Luna De Sutter
Favorite
Debiec-Rychter, Maria

KU Leuven
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Maria Debiec-Rychter
Favorite
Dei Tos, Angelo

Azienda Ospedaliera di Padova
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Angelo Dei Tos
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Angelo Dei Tos
Favorite
Dela Cruz, Filemon

Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Filemon Dela Cruz
Favorite
Delattre, Olivier

Institut Curie Research Center
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Olivier Delattre
Favorite
Delegido-Garcia, Ana

“La Arrixaca” Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Ana Delegido-Garcia
Favorite
Demetri, George

Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
George Demetri
Favorite
Demicco, Elizabeth

Mount Sinai Hospital, University of Toronto
Debate on Genomics: Should Patients with Sarcoma Have Next Generation Sequencing Performed at the Time of Diagnosis?
Location: VCC, East Exhibition Hall A
Elizabeth Demicco
Favorite
Deng, Jie

University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Jie Deng
Favorite
Deroose, Jan

Martini ziekenhuis
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Jan Deroose
Favorite
Desai, Anant

University Hospital Birmingham NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Anant Desai
Favorite
Desai, Jayesh

Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Jayesh Desai
Favorite
Desar, Ingrid

Radboud University Medical Centre
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Ingrid Desar
Favorite
Deshpande, Hari

Yale
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Hari Deshpande
Favorite
Devalck, C

Paediatric Haematology and Oncology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
C Devalck
Favorite
Dewji, Simin

Mount Sinai Hospital
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Simin Dewji
Favorite
Dhami, Pawan

University College London Cancer Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Pawan Dhami
Favorite
Dhir, Aditi

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Aditi Dhir
Favorite
Di Lorenzo, Giorgia

Fondazione IRCCS Istituto Nazionale dei Tumori-Università degli studi Milano-Bicocca
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Giorgia Di Lorenzo
Favorite
di Paolo, P.L.

Department of Radiology, Bambino Gesù Children's Hospital, IRCCS
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
P.L. di Paolo
Favorite
Dickson, Brendan

Mount Sinai Hospital
Paper 32 - ESTABLISHMENT OF HIGH-GRADE SOFT TISSUE SARCOMA METASTATIC DISEASE MURINE MODELS
Brendan Dickson
Favorite
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Brendan Dickson
Favorite
Dickson, Brendan C

Department of Laboratory Medicine and Pathobiology, University of Toronto; Department of Pathology and Laboratory Medicine
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Brendan C Dickson
Favorite
Dickson, Mark

Memorial Sloan Kettering Cancer Center
Debate on Genomics: Should Patients with Sarcoma Have Next Generation Sequencing Performed at the Time of Diagnosis?
Location: VCC, East Exhibition Hall A
Mark Dickson
Favorite
Mentorship Session 1: How to Set Up Clinical Trials
Mark Dickson
Favorite
Session 3: Medical & Pediatric Oncology and Clinical Trials
Location: VCC, East Exhibition Hall A
Mark Dickson
Favorite
Session 6: Radiation Oncology & Oligometastatic Disease
Location: VCC, East Exhibition Hall A
Mark Dickson
Favorite
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Mark Dickson
Favorite
Dijkstra, Sander D.S.

Department of Surgery, Leiden University Medical Center
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Sander D.S. Dijkstra
Favorite
Dileo, Palma

University College London Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Palma Dileo
Favorite
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Palma Dileo
Favorite
Dima, Laura

Bayer HealthCare SAS, Medical Affairs
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Laura Dima
Favorite
Dirksen, Uta

University Hospital Essen, Pediatrics III, Essen, Germany
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Uta Dirksen
Favorite
Djafarrian, Reza

Centre Hospitalier Universitaire Vaudois
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Reza Djafarrian
Favorite
Dorsey*, Jen

Lunenfeld Tanenbaum Research Institute/Mount Sinai Hospital
Paper 32 - ESTABLISHMENT OF HIGH-GRADE SOFT TISSUE SARCOMA METASTATIC DISEASE MURINE MODELS
Jen Dorsey*
Favorite
Doung, Yee

Oregon Health & Science University
Paper 84 - NATURAL LANGUAGE PROCESSING OF PATHOLOGY REPORTS IDENTIFIES SOFT TISSUE SARCOMAS MISSED BY INTERNATIONAL CLASSIFICATION OF DISEASES CODES IN THE VA NATIONAL DATABASE
Yee Doung
Favorite
Drechsler, Christine

The healthcare business of Merck KGaA
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Christine Drechsler
Favorite
Drusbosky, Leylah

Guardant Health
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Leylah Drusbosky
Favorite
D'Silva, Dhiren

PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Dhiren D'Silva
Favorite
Duarte, Carlos

Instituto Nacional de Cancerología
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Carlos Duarte
Favorite
DuBois, Steven

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Steven DuBois
Favorite
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Steven DuBois
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Steven DuBois
Favorite
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Steven DuBois
Favorite
Dufresne, Armelle

Medical Cancer Department, Centre Léon Bérard
Session 7: GIST & Other Sarcomas with Actionable Targets
Location: VCC, East Exhibition Hall A
Armelle Dufresne
Favorite
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Armelle Dufresne
Favorite
Durland-Busbice, Sara

Boehringer Ingelheim Pharmaceuticals Inc
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Sara Durland-Busbice
Favorite
E
Eilber, Fritz

UCLA Health
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Fritz Eilber
Favorite
Ekert, Paul

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Paul Ekert
Favorite
El Zein, Sophie

Department of Biopathology, Institut Curie, Paris Sciences et Lettres Research University
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Sophie El Zein
Favorite
El-Khoueiry, Anthony

University of Southern California Norris Comprehensive Cancer Center
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Anthony El-Khoueiry
Favorite
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Anthony El-Khoueiry
Favorite
Endo, Makoto

Kyushu University Department of Orthopaedic Surgery
Session 8: Adolescent & Young Adult Sarcoma
Location: VCC, East Exhibition Hall A
Makoto Endo
Favorite
Esdar, Christina

The healthcare business of Merck KGaA
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Christina Esdar
Favorite
Espejo Freire, Andrea

University of Miami
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Andrea Espejo Freire
Favorite
Espejo-Freire, Andrea

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Andrea Espejo-Freire
Favorite
Eulo, Vanessa

University of Alabama at Birmingham
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Vanessa Eulo
Favorite
Evans, Abigail

Euro Ewing Consortium
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Abigail Evans
Favorite
Eward, William

Department of Orthopedic Surgery, Duke University
Session 11: Surgery (Orthopedic, Reconstructive)
Location: VCC, East Exhibition Hall A
William Eward
Favorite
F
Fabbroni, Chiara

Fondazione IRCCS Istituto Nazionale dei Tumori MILANO
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Chiara Fabbroni
Favorite
Fahs, Assil

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Assil Fahs
Favorite
Fairweather, Mark

Brigham and Women's Hospital/Harvard Medical School
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Mark Fairweather
Favorite
Fakih, Marwan

City of Hope Comprehensive Cancer Center
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Marwan Fakih
Favorite
Fang, Yan

Memorial Sloan Kettering Cancer Center
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Yan Fang
Favorite
Farag, Mina

McGill University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Mina Farag
Favorite
Farma, Jeffrey

Fox Chase Cancer Center
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Jeffrey Farma
Favorite
Farmer, Catherine

Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Catherine Farmer
Favorite
Faron, Matthieu

Department of Surgical Oncology, Institut Gustave Roussy
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Matthieu Faron
Favorite
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Matthieu Faron
Favorite
Feber, Andrew

Clinical Genomics Translational Research, Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Andrew Feber
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Andrew Feber
Favorite
Federman, Noah

David Geffen School of Medicine, UCLA Jonsson Comprehensive Cancer Center
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Noah Federman
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Noah Federman
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Noah Federman
Favorite
Feig, Barry

University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Barry Feig
Favorite
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Barry Feig
Favorite
Feng, Xiaolan

Tom Baker Cancer Centre
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Xiaolan Feng
Favorite
Feng, Xiaolan

BC Cancer
Paper 38 - PATIENT OUTCOMES IN METASTATIC EWING SARCOMA RESTRICTED TO PULMONARY METASTASES TREATED WITH WHOLE LUNG RADIATION
Xiaolan Feng
Favorite
Feng, Xiaolan

Cumming School of Medicine, University of Calgary, Tom Baker Cancer Center
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Xiaolan Feng
Favorite
Fenwick, Nicola

University of Birmingham
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Nicola Fenwick
Favorite
Ferguson, Peter

Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto; CanSaRCC, Princess Margaret Cancer Centre, Toronto
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Peter Ferguson
Favorite
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Peter Ferguson
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Peter Ferguson
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Peter Ferguson
Favorite
Fernández, Juan Angel

"La Arrixaca" University Hospital
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Juan Angel Fernández
Favorite
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Juan Angel Fernández
Favorite
Ferrari, Andrea

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Andrea Ferrari
Favorite
Ferrari, Stefano

Istituto Ortopedico Rizzoli
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Stefano Ferrari
Favorite
Feuerbach, Lars

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Lars Feuerbach
Favorite
Fice, Michael

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Michael Fice
Favorite
Figueiredo, Rodrigo

The Newcastle upon Tyne Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Rodrigo Figueiredo
Favorite
Finch, Alison

Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Alison Finch
Favorite
Fiore, Marco

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Marco Fiore
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Marco Fiore
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Marco Fiore
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Marco Fiore
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Marco Fiore
Favorite
Flanagan, Adrienne

University College London Cancer Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Adrienne Flanagan
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Adrienne Flanagan
Favorite
Fletcher, Jonathan

Brigham and Women’s Hospital
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Jonathan Fletcher
Favorite
Fleuren, Emmy

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Emmy Fleuren
Favorite
Focaccia, Marco

IRCCS Rizzoli Orthopedic Institute, Orthopedic Oncology Unit
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Marco Focaccia
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Marco Focaccia
Favorite
Fordham, Ashleigh

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Ashleigh Fordham
Favorite
Ford, Samuel

University Hospitals Birmingham NHS Foundation Trust
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Samuel Ford
Favorite
Fourquet, Fourquet

3. OncoSarc, INSERM U1037, Cancer Research Center in Toulouse,
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Fourquet Fourquet
Favorite
Fox, Amanda

University of Michigan
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Amanda Fox
Favorite
Franza, Andrea

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Andrea Franza
Favorite
Franz, Emily

Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University; Center for Childhood Cancer, Nationwide Children’s Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Emily Franz
Favorite
French, Jeremy

The Newcastle upon Tyne Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Jeremy French
Favorite
Fröhling, Stefan

Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Stefan Fröhling
Favorite
Frutos-Bernal, MDolores

“La Arrixaca” Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
MDolores Frutos-Bernal
Favorite
Fucimetiere, Francoise

Department of Oncology, Centre Léon Bérard
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Francoise Fucimetiere
Favorite
Fumagalli, Elena

Istituto Nazionale Tumori
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Elena Fumagalli
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Elena Fumagalli
Favorite
Furness, Andrew

Royal Marsden Hopsital
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Andrew Furness
Favorite
Futreal, P Andrew

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
P Andrew Futreal
Favorite
G
Gómez-Pérez, Beatriz

"La Arrixaca" Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Beatriz Gómez-Pérez
Favorite
Gala, Kunal

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Kunal Gala
Favorite
Gallego, Soledad

Vall d'Hebron Research Institute
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Soledad Gallego
Favorite
Galor, Alon

University of Oxford, Wellcome Centre for Human Genetics
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Alon Galor
Favorite
Ganjoo, Kristen

Stanford Cancer Center, Stanford University
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Kristen Ganjoo
Favorite
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Kristen Ganjoo
Favorite
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Kristen Ganjoo
Favorite
Garcia Ortega, Dorian

National Cancer Institute (Mexico)
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Dorian Garcia Ortega
Favorite
Garcia-Ortega, Dorian

National Cancer Institute Mexico
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Dorian Garcia-Ortega
Favorite
Garrido-Laguna, Ignacio

Huntsman Cancer Institute at the University of Utah
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Ignacio Garrido-Laguna
Favorite
Gaspar, Nathalie

Gustave Roussy
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Nathalie Gaspar
Favorite
Gatenby, Bob

Moffitt
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Bob Gatenby
Favorite
Gaunt, Piers

University of Birmingham
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Piers Gaunt
Favorite
Gazendam, Aaron

McMaster University
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Aaron Gazendam
Favorite
Gelderblom, Hans

Leiden University Medical Center, Leiden, Netherlands
Mentorship Session 9: How to Get Your Paper Published
Hans Gelderblom
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Hans Gelderblom
Favorite
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Hans Gelderblom
Favorite
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Hans Gelderblom
Favorite
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Hans Gelderblom
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Hans Gelderblom
Favorite
Geng, Junxian

Boehringer Ingelheim Pharmaceuticals, Inc.
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Junxian Geng
Favorite
Geoerger, Birgit

Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, INSERM U1015
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Birgit Geoerger
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Birgit Geoerger
Favorite
George, Suzanne

Dana-Farber Cancer Institute
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Suzanne George
Favorite
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Suzanne George
Favorite
Gerrand, Craig

Royal National Orthopaedic Hospital NHS Trust
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Craig Gerrand
Favorite
Ghert, Michelle

McMaster University
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Michelle Ghert
Favorite
Gil, Elena

“La Arrixaca” Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Elena Gil
Favorite
Gillis, Taylor

School of Medicine, University of Nevada Las Vegas
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Taylor Gillis
Favorite
Gill, Jonathan

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Jonathan Gill
Favorite
Gil-Vazquez, Pedro J

"La Arrixaca" Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Pedro J Gil-Vazquez
Favorite
Gimarc, David

Department of Radiology, University of Colorado School of Medicine - Anschutz Medical Campus
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
David Gimarc
Favorite
Giraudo, C.

Institute of Radiology, Department of Medicine-DIMED, University of Padova
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
C. Giraudo
Favorite
Gitelis, Steven

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Steven Gitelis
Favorite
Gladdy, Rebecca

Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto; CanSaRCC, Princess Margaret Cancer Centre, Toronto
Mentorship Session 6: Wellness/Work Life Balance
Rebecca Gladdy
Favorite
Session 10: Retroperitoneal and Abdominal Sarcomas
Location: VCC, East Exhibition Hall A
Rebecca Gladdy
Favorite
Session 11: Surgery (Orthopedic, Reconstructive)
Location: VCC, East Exhibition Hall A
Rebecca Gladdy
Favorite
Session 2: Sarcoma Biology & 'omics
Location: VCC, East Exhibition Hall A
Rebecca Gladdy
Favorite
Paper 32 - ESTABLISHMENT OF HIGH-GRADE SOFT TISSUE SARCOMA METASTATIC DISEASE MURINE MODELS
Rebecca Gladdy
Favorite
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Rebecca Gladdy
Favorite
Glade Bender, Julia

Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Julia Glade Bender
Favorite
Glosli, H.

Department of Paediatric Research and Department of Paediatric and Adolescent Medicine, Oslo University Hospital
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
H. Glosli
Favorite
Godwin, J. Luke

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
J. Luke Godwin
Favorite
Goel, Neha

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Neha Goel
Favorite
Gokgoz, Nalan

Lunenfeld-Tanenbaum Research Institute
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Nalan Gokgoz
Favorite
Gokhale, Prafulla C.

Dana Farber Cancer Institute
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Prafulla C. Gokhale
Favorite
González, Jose Antonio

Hospital de La Santa Creu I Sant Pau
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Jose Antonio González
Favorite
Gonzalez, Felipe

Instituto Nacional de Cancerología
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Felipe Gonzalez
Favorite
Goodboy, Christine

Children's Hospital of Philadelphia
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Christine Goodboy
Favorite
Gordon, Michael

HonorHealth Research Institute
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Michael Gordon
Favorite
Gordon, Nancy

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Nancy Gordon
Favorite
Gorlick, Richard

MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Richard Gorlick
Favorite
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Richard Gorlick
Favorite
Goto, Koichi

National Cancer Center Hospital East
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Koichi Goto
Favorite
Goulding, Krista

Department of Orthopedic Surgery, Mayo Clinic
Paper 85 - MEANINGFUL INTERPRETATION OF TORONTO EXTREMITY SALVAGE SCORE IN PEOPLE WITH SOFT-TISSUE SARCOMA USING RASCH ANALYSIS
Krista Goulding
Favorite
Gounder, Mrinal

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Mrinal Gounder
Favorite
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Mrinal Gounder
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Mrinal Gounder
Favorite
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Mrinal Gounder
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Mrinal Gounder
Favorite
Grünhagen, Dirk

Erasmus Medical Center
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Dirk Grünhagen
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Dirk Grünhagen
Favorite
Griffin, Anthony

Mount Sinai Hospital
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Anthony Griffin
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Anthony Griffin
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Anthony Griffin
Favorite
Griffin, Katherine

University of California, Davis
Paper 31 - ENGINEERED BONE MARROW: A COMPLEX MODEL FOR PRIMARY OSTEOSARCOMA TUMORIGENESIS
Katherine Griffin
Favorite
Griffiths, Pip

IQVIA
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Pip Griffiths
Favorite
Grignani, Giovanni

Department of Medical Oncology-Sarcoma Unit, Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Giovanni Grignani
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Giovanni Grignani
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Giovanni Grignani
Favorite
Gronchi, Alessandro

Fondazione IRCCS Istituto Nazionale dei Tumori
Mentorship Session 5: Setting Up Collaborations in Rare Tumors
Alessandro Gronchi
Favorite
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Alessandro Gronchi
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Alessandro Gronchi
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Alessandro Gronchi
Favorite
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Alessandro Gronchi
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Alessandro Gronchi
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Alessandro Gronchi
Favorite
Gross, Amy

Center for Childhood Cancer, Nationwide Children's Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Amy Gross
Favorite
Grossman, Joseph

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Joseph Grossman
Favorite
Groundland, John

Huntsman Cancer Institute
Paper 74 - TOTAL SIZE OF POST-OPERATIVE SEROMA CORRELATES WITH WOUND COMPLICATIONS FOLLOWING SOFT-TISSUE SARCOMA RESECTION
John Groundland
Favorite
Guadagnolo, B. Ashleigh

MDACC
Session 6: Radiation Oncology & Oligometastatic Disease
Location: VCC, East Exhibition Hall A
B. Ashleigh Guadagnolo
Favorite
Guan, Peiyong

Genome Institute of Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Peiyong Guan
Favorite
Guedes, Brian

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Brian Guedes
Favorite
Guinot, Aurélie

institut d'oncologie et hématologie pédiatrique
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Aurélie Guinot
Favorite
Gulamhusein, Aziz

The Christie NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Aziz Gulamhusein
Favorite
Gulia, Aashish

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Aashish Gulia
Favorite
Gundavda, Manit

Kokilaben Dhirubhai Ambani Hospital, Mumbai, India
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Manit Gundavda
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Manit Gundavda
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Manit Gundavda
Favorite
Gundle, Kenneth

Oregon Health & Science University | Portland VA Medical Center
Paper 84 - NATURAL LANGUAGE PROCESSING OF PATHOLOGY REPORTS IDENTIFIES SOFT TISSUE SARCOMAS MISSED BY INTERNATIONAL CLASSIFICATION OF DISEASES CODES IN THE VA NATIONAL DATABASE
Kenneth Gundle
Favorite
Gunther, Kate

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Kate Gunther
Favorite
Gupta, Abha

Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Ontario, Canada; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Ontario, Canada; CanSaRCC, Princess Margaret Cancer Center, Ontario, Canada
Mentorship Session 4: Program Development: Starting Sarcoma Programs to Growing Established Programs
Abha Gupta
Favorite
Session 13: Epidemiology, Informatics, Population Health, Health Outcomes
Location: VCC, East Exhibition Hall A
Abha Gupta
Favorite
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Abha Gupta
Favorite
Gupta, Gaurav

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Gaurav Gupta
Favorite
Gupta, Sudeep

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Sudeep Gupta
Favorite
Gyorki, David

Peter MacCallum Cancer Centre
Session 10: Retroperitoneal and Abdominal Sarcomas
Location: VCC, East Exhibition Hall A
David Gyorki
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
David Gyorki
Favorite
H
H.A. Bemelmans, Marc

Department of Surgery, Maastricht University Medical Center+, Maastricht
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Marc H.A. Bemelmans
Favorite
Haase, Kerstin

Francis Crick Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Kerstin Haase
Favorite
Haas, Rick

NKI-AvL
Mentorship Session 8: How to Get Involved in CTOS
Rick Haas
Favorite
Haber, Michelle

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Michelle Haber
Favorite
Hackbarth, Donald

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Donald Hackbarth
Favorite
Haddock, Michael

Mayo Clinic
Paper 39 - PENCIL BEAM SCANNING PROTON RADIOTHERAPY FOR SACRAL CHORDOMAS: THE MAYO CLINIC EXPERIENCE
Michael Haddock
Favorite
Haddox, Candace

Dana-Farber Cancer Institute
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Candace Haddox
Favorite
Hadzic, Armin

Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Armin Hadzic
Favorite
Hames-Fathi, Shadi

University College London Cancer Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Shadi Hames-Fathi
Favorite
Hamm, Jeremy

BC Cancer-Cancer Surveillance & Outcomes
Paper 38 - PATIENT OUTCOMES IN METASTATIC EWING SARCOMA RESTRICTED TO PULMONARY METASTASES TREATED WITH WHOLE LUNG RADIATION
Jeremy Hamm
Favorite
Hanna, Diana

USC Norris Comprehensive Cancer Center
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Diana Hanna
Favorite
Hannay, Jonathan

The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Jonathan Hannay
Favorite
Harrington, Kevin

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Kevin Harrington
Favorite
Harrison, Douglas

University of Texas MD Anderson Cancer Center
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Douglas Harrison
Favorite
Paper 50 - OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE SARCOMA COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Douglas Harrison
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Douglas Harrison
Favorite
Hart, Jesse

Department of Pathology, Lifespan Laboratories, Rhode Island Hospital
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Jesse Hart
Favorite
Hayashi, Masanori

Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Masanori Hayashi
Favorite
Hayden, James

Oregon Health & Science University
Paper 84 - NATURAL LANGUAGE PROCESSING OF PATHOLOGY REPORTS IDENTIFIES SOFT TISSUE SARCOMAS MISSED BY INTERNATIONAL CLASSIFICATION OF DISEASES CODES IN THE VA NATIONAL DATABASE
James Hayden
Favorite
Hayes, Andrew

Royal Marsden Hospital
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Andrew Hayes
Favorite
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Andrew Hayes
Favorite
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Andrew Hayes
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Andrew Hayes
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Andrew Hayes
Favorite
Hayes-Jordan, Andrea

Lineberger Comprehensive Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Andrea Hayes-Jordan
Favorite
Healey, John

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
John Healey
Favorite
Heinrich, Michael

Oregon Health and Science University
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Michael Heinrich
Favorite
Heinzmann, Sebastian

F. Hoffmann-La Roche Ltd
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Sebastian Heinzmann
Favorite
Heise, Rachel

Weill Cornell Medicine
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Rachel Heise
Favorite
Hendrickson, Peter

Duke Univeristy
Paper 30 - SUCCESS AND CHALLENGES OF GENERATING A GENETICALLY ENGINEERED MOUSE MODEL OF CIC-DUX4 SARCOMA
Peter Hendrickson
Favorite
Henning, Jan-Willem

Tom Baker Cancer Centre, University of Calgary
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Jan-Willem Henning
Favorite
Hildebrand, Karys

University of Calgary
Paper 56 - STING ACTIVATION AS AN IMMUNOGENIC THERAPY FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Karys Hildebrand
Favorite
Hildebrand, Kurt

University of Calgary
Paper 56 - STING ACTIVATION AS AN IMMUNOGENIC THERAPY FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Kurt Hildebrand
Favorite
Hinck, Andrew

Department of Structural Biology, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Andrew Hinck
Favorite
Hinckley, John

Battelle Memorial Institute
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
John Hinckley
Favorite
Hindi, Nadia

Fundacion Jimenez Diaz University Hospital/HG Villalba and Instituto de Investigaciones Sanitarias Fundación Jimenez Diaz
Session 1: Telemedicine, Virtual Tumor Boards and Multidisciplinary Care
Location: VCC, East Exhibition Hall A
Nadia Hindi
Favorite
Session 13: Epidemiology, Informatics, Population Health, Health Outcomes
Location: VCC, East Exhibition Hall A
Nadia Hindi
Favorite
Session 9: Immunology & Immunotherapy
Location: VCC, East Exhibition Hall A
Nadia Hindi
Favorite
Hiniker, Susan

Stanford University
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Susan Hiniker
Favorite
Hirbe, Angela

Washington University in St. Louis
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Angela Hirbe
Favorite
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Angela Hirbe
Favorite
Hodson, James

University Hospital Birmingham NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
James Hodson
Favorite
Hohenberger, Peter

University Hospital Essen
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Peter Hohenberger
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Peter Hohenberger
Favorite
Holloway, Caroline

BC Cancer
Paper 38 - PATIENT OUTCOMES IN METASTATIC EWING SARCOMA RESTRICTED TO PULMONARY METASTASES TREATED WITH WHOLE LUNG RADIATION
Caroline Holloway
Favorite
Hompes, Daphne

University Hospitals Gasthuisberg
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Daphne Hompes
Favorite
Hompland, Ivar

Oslo University Hospital
Paper 53 - THERE’S NO PLACE LIKE HOME. TREATING ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA AT HOME
Ivar Hompland
Favorite
Hong, David

The University of Texas MD Anderson Cancer Center
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
David Hong
Favorite
Honore, Charles

Department of Surgical Oncology, Institut Gustave Roussy
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Charles Honore
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Charles Honore
Favorite
Hornstein, Nicholas

MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Nicholas Hornstein
Favorite
Ho, Thanh

Mayo Clinic
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Thanh Ho
Favorite
Houdek, Matthew

Mayo Clinic
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Matthew Houdek
Favorite
Hoyt, David

University of Utah School of Medicine
Paper 74 - TOTAL SIZE OF POST-OPERATIVE SEROMA CORRELATES WITH WOUND COMPLICATIONS FOLLOWING SOFT-TISSUE SARCOMA RESECTION
David Hoyt
Favorite
Huang, Michael

AmMax Biopharma
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Michael Huang
Favorite
Huang, Paul

The Institute for Cancer Research
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Paul Huang
Favorite
Hu, James

University of Southern California Norris Comprehensive Cancer Center
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
James Hu
Favorite
Hunt, Kelly

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Kelly Hunt
Favorite
I
Iadecola, Sara

Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Sara Iadecola
Favorite
Ibáñez, Noelia

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Noelia Ibáñez
Favorite
Ibrahim, Toni

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Toni Ibrahim
Favorite
Ijsselsteijn, Marieke

Department of Pathology, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Marieke Ijsselsteijn
Favorite
IJzerman, Nikki

Netherlands Cancer Institute and Erasmus MC Cancer Institute
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Nikki IJzerman
Favorite
Ilaslan, Hakan

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Hakan Ilaslan
Favorite
Indelicato, Daniel

University of Florida
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Daniel Indelicato
Favorite
Ingham, Matthew

New York Presbyterian Hospital/Columbia University Medical Center
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Matthew Ingham
Favorite
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Matthew Ingham
Favorite
Ingley, Katrina

Sarcoma Department, University College Hospital, London, UK
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Katrina Ingley
Favorite
Ingram, Davis

MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Davis Ingram
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Davis Ingram
Favorite
Isabelle, Martin

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Martin Isabelle
Favorite
Islam, S. M. Ashiqul

University of California San Diego
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
S. M. Ashiqul Islam
Favorite
Isnardi, Vanina

centre léon Berard
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Vanina Isnardi
Favorite
Italiano, Antoine

Institut Bergonié
Session 9: Immunology & Immunotherapy
Location: VCC, East Exhibition Hall A
Antoine Italiano
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Antoine Italiano
Favorite
Iturregui, Jose

Mayo Clinic
Paper 85 - MEANINGFUL INTERPRETATION OF TORONTO EXTREMITY SALVAGE SCORE IN PEOPLE WITH SOFT-TISSUE SARCOMA USING RASCH ANALYSIS
Jose Iturregui
Favorite
Iwata, Shintaro

National Cancer Center Hospital
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Shintaro Iwata
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Shintaro Iwata
Favorite
J
Jakob, Jens

Mannheim University Medical Center
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Jens Jakob
Favorite
Janeway, Katie

Dana-Farber and Children's Hospital
Mentorship Session 3: Biobanking and Correlative Science: How to Establish and Learn about Rare Tumor Biology
Katie Janeway
Favorite
Session 14: Bone Sarcomas
Location: VCC, East Exhibition Hall A
Katie Janeway
Favorite
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Katie Janeway
Favorite
Jayadeva, Girish

Boehringer Ingelheim International GmbH
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Girish Jayadeva
Favorite
Jenney, M

Cardiff and Vale UHB, Paeds Oncology
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
M Jenney
Favorite
Jeys, Lee

Royal Orthopaedic Hospital
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Lee Jeys
Favorite
Joensuu, Heikki

Helsinki University Central Hospital and University of Helsinki
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Heikki Joensuu
Favorite
Johnson, Kirk

AmMax Biopharma
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Kirk Johnson
Favorite
Johnstone, Candice

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Candice Johnstone
Favorite
Johnston, Fabian

The Johns Hopkins University School of Medicine
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Fabian Johnston
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Fabian Johnston
Favorite
Johnston, Wendy

Mount Sinai Hopsital
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Wendy Johnston
Favorite
Jonczak, Emily

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Emily Jonczak
Favorite
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Emily Jonczak
Favorite
Jones, Conor

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Conor Jones
Favorite
Jones, Kevin

University of Utah, Huntsman Cancer Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Kevin Jones
Favorite
Paper 16 - EWSR1:ATF1 BINDS PROMOTER AND ENHANCER REGIONS TO REPROGRAM TRANSCRIPTION IN CLEAR CELL SARCOMA
Kevin Jones
Favorite
Paper 74 - TOTAL SIZE OF POST-OPERATIVE SEROMA CORRELATES WITH WOUND COMPLICATIONS FOLLOWING SOFT-TISSUE SARCOMA RESECTION
Kevin Jones
Favorite
Jones, Robert

Aintree University Hospital
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Robert Jones
Favorite
Jones, Robin

Royal Marsden Hospital
Mentorship Session 7: How to Deal with Conflict
Robin Jones
Favorite
Jones, Robin

The Royal Marsden NHS Foundation Trust
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Robin Jones
Favorite
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Robin Jones
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Robin Jones
Favorite
Jones, Robin Lewis

Royal Marsden Hospital and Institute of Cancer Research
Paper 40 - PRIMARY CARDIAC AND GREAT VESSEL SARCOMAS: MULTI-MODALITY MANAGEMENT AND CLINICAL OUTCOMES AT THE ROYAL MARSDEN HOSPITAL 1987-2021
Robin Lewis Jones
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Robin Lewis Jones
Favorite
Jordan, Justin T

Pappas Center for Neuro-oncology, Massachusetts General Hospital
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Justin T Jordan
Favorite
Joyce, Daniel

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Daniel Joyce
Favorite
Jubenville, Tyler

University of Minnesota
Paper 29 - ALTERED EPIGENETIC HOMEOSTASIS YIELDS THERAPEUTIC VULNERABILITIES IN NEUROFIBROMATOSIS TYPE 1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Tyler Jubenville
Favorite
Jung, Sungmi

McGill University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Sungmi Jung
Favorite
Just, Marissa

Indiana University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Marissa Just
Favorite
K
Kalbasi, Anusha

Department of Radiation Oncology, UCLA
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Anusha Kalbasi
Favorite
Kanerva, Jukka

Helsinki University Hospital
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Jukka Kanerva
Favorite
Kannan, Bavani

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Bavani Kannan
Favorite
Kasper, Bernd

University of Heidelberg, Mannheim University Medical Center, Mannheim Cancer Center, Sarcoma Unit,
Session 12: Desmoid Fibromatosis
Location: VCC, East Exhibition Hall A
Bernd Kasper
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Bernd Kasper
Favorite
Keaney, Heather

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Heather Keaney
Favorite
Kearl, Tyce

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Tyce Kearl
Favorite
Keilson, Jessica

Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Jessica Keilson
Favorite
Kelly, Ciara

Memorial Sloan Kettering Cancer Center
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Ciara Kelly
Favorite
Kelly-Morland, Christian

The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Christian Kelly-Morland
Favorite
Kelly, Tracy

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Tracy Kelly
Favorite
Kendal, Joseph

University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Joseph Kendal
Favorite
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Joseph Kendal
Favorite
Keung, Emily

University of Texas MD Anderson Cancer Center
Session 10: Retroperitoneal and Abdominal Sarcomas
Location: VCC, East Exhibition Hall A
Emily Keung
Favorite
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Emily Keung
Favorite
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Emily Keung
Favorite
Key, Catherine

Sheffield Teaching Hospital NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Catherine Key
Favorite
Khalili, Korosh

Princess Margaret Cancer Centre
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Korosh Khalili
Favorite
Khandekar, Azhar

University of California San Diego
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Azhar Khandekar
Favorite
Khan, Maria

University of Birmingham
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Maria Khan
Favorite
Khanna, Nehal

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Nehal Khanna
Favorite
Kilpatrick, Scott

Cleveland Clinic Lerner College of Medicine
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Scott Kilpatrick
Favorite
Kim, AeRang

Children's National Hospital
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
AeRang Kim
Favorite
Kim, Edward

University of Washington/Fred Hutch Cancer Center
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Edward Kim
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Edward Kim
Favorite
Kim, Pauline

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Pauline Kim
Favorite
Kim, Raymond H

Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, Sinai Health System, Hospital for Sick Children, University of Toronto
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Raymond H Kim
Favorite
King, David

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
David King
Favorite
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
David King
Favorite
Kinnaman, Michael

Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Michael Kinnaman
Favorite
Kirsch, David

Duke University
Mentorship Session 2: How to Grant Write
David Kirsch
Favorite
Session 4: Preclinical Models & Translational Research
Location: VCC, East Exhibition Hall A
David Kirsch
Favorite
Paper 30 - SUCCESS AND CHALLENGES OF GENERATING A GENETICALLY ENGINEERED MOUSE MODEL OF CIC-DUX4 SARCOMA
David Kirsch
Favorite
Kirton, Laura

University of Birmingham
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Laura Kirton
Favorite
Kleinerman, Eugenie

MD Anderson Cancer Center
Paper 88 - A NOVEL CD103+ CDC1 DENDRITIC CELL VACCINE FOR OSTEOSARCOMA
Eugenie Kleinerman
Favorite
Klein, Evan

Rush Medical College
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Evan Klein
Favorite
Klooster, Isabella

Brigham and Women's Hospital
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Isabella Klooster
Favorite
Kostogryz, Oleg

National Academy of Medical Sciences
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Oleg Kostogryz
Favorite
Kota, Kishore

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Kishore Kota
Favorite
Ko, Tun Kiat

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Tun Kiat Ko
Favorite
Koucheki, Robert

University of Toronto
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Robert Koucheki
Favorite
Kovach, Alexander

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Alexander Kovach
Favorite
Kozlowski, Erin

SARC
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Erin Kozlowski
Favorite
Krailo, Mark

Children's Oncology Group
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Mark Krailo
Favorite
Krakorova, Dagmar

Masaryk Memorial Cancer Institute
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Dagmar Krakorova
Favorite
Kramer, Sonja

Institute of Oncology Ljubljana
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Sonja Kramer
Favorite
Krasnick, Bradley

Washington University
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
Bradley Krasnick
Favorite
Krishnan, Sandhya

The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Sandhya Krishnan
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Sandhya Krishnan
Favorite
Kühne, Thomas

University Children´s Hospital Basel, Department of Oncology/ Haematology, Basel, Switzerland
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Thomas Kühne
Favorite
Kulkarni, Suyash

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Suyash Kulkarni
Favorite
Kumar, Prasanna

Daiichi Sankyo, Inc.
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Prasanna Kumar
Favorite
Kummar, Shivaani

Oregon Health & Science University
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Shivaani Kummar
Favorite
Kviat, Lorna

Royal Marsden NHS Foundation Trust
Paper 40 - PRIMARY CARDIAC AND GREAT VESSEL SARCOMAS: MULTI-MODALITY MANAGEMENT AND CLINICAL OUTCOMES AT THE ROYAL MARSDEN HOSPITAL 1987-2021
Lorna Kviat
Favorite
Kwong, Winghan Jackie

Daiichi Sankyo, Inc.
Paper 87 - PATIENT-REPORTED SYMPTOM IMPROVEMENT IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR: A CROSS-SECTIONAL SURVEY IN THE UNITED STATES
Winghan Jackie Kwong
Favorite
Kyula-Currie, Joan

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Joan Kyula-Currie
Favorite
L
Laack, Nadia

Mayo Clinic
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Nadia Laack
Favorite
Laas, Enora

Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Enora Laas
Favorite
Ladra, Matthew

Johns Hopkins University School of Medicine
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Matthew Ladra
Favorite
Laetsch, Theodore

The Children’s Hospital of Philadelphia, University of Pennsylvania
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Theodore Laetsch
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Theodore Laetsch
Favorite
Lahat, Guy

TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Guy Lahat
Favorite
Lamhamedi-Cherradi, Salah-Eddine

MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Salah-Eddine Lamhamedi-Cherradi
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Salah-Eddine Lamhamedi-Cherradi
Favorite
Lapouble, Eve

Curie Institute
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Eve Lapouble
Favorite
Largaespada, David

University of Minnesota
Paper 29 - ALTERED EPIGENETIC HOMEOSTASIS YIELDS THERAPEUTIC VULNERABILITIES IN NEUROFIBROMATOSIS TYPE 1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
David Largaespada
Favorite
Larsson, Alex

University of Minnesota
Paper 29 - ALTERED EPIGENETIC HOMEOSTASIS YIELDS THERAPEUTIC VULNERABILITIES IN NEUROFIBROMATOSIS TYPE 1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Alex Larsson
Favorite
Laskar, Siddharth

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Siddharth Laskar
Favorite
Lau, Loretta

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Loretta Lau
Favorite
Laurenzi, Andrea

Division of Hepatobiliary Surgery and Organ Transplantation Azienda Ospedaliero-Universitaria di Bologna - IRCCS
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Andrea Laurenzi
Favorite
Lazar, Alexander

The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Alexander Lazar
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Alexander Lazar
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Alexander Lazar
Favorite
Lazarides, Alexander

Moffitt Cancer Center
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Alexander Lazarides
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Alexander Lazarides
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Alexander Lazarides
Favorite
Le Cesne, Axel

Department of Medicine, Gustave Roussy
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Axel Le Cesne
Favorite
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Axel Le Cesne
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Axel Le Cesne
Favorite
Le Pommellet, Helene

Novetech Surgery
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Helene Le Pommellet
Favorite
Le Roux, Ozgun

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Ozgun Le Roux
Favorite
Leach, Kent

University of California, Davis/Orthopaedic Surgery and Biomedical Engineering
Paper 31 - ENGINEERED BONE MARROW: A COMPLEX MODEL FOR PRIMARY OSTEOSARCOMA TUMORIGENESIS
Kent Leach
Favorite
Leavey, Patrick

UT Southwestern
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Patrick Leavey
Favorite
Lechner, Matt

University College London Cancer Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Matt Lechner
Favorite
Lee, Elizabeth

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Elizabeth Lee
Favorite
Lee, Jing Yi

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Jing Yi Lee
Favorite
Lee, Linus

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Linus Lee
Favorite
Leemans, A.

Image Sciences Institute, University Medical Center Utrecht
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
A. Leemans
Favorite
Leeper, Brittaney A.

Dana Farber Cancer Institute
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Brittaney A. Leeper
Favorite
Lesegretain, Arnaud

Daiichi Sankyo, Inc.
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Arnaud Lesegretain
Favorite
Lesluyes, Tom

Francis Crick Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Tom Lesluyes
Favorite
Lessnick, Stephen

Abigail Wexner Research Institute at Nationwide Children's Hospital and The Ohio State University
Paper 95 - STUDYING THE ROLE OF FLI PORTION OF EWS: FLI IN TRANSCRIPTION REGULATION VIA MODULATION OF CHROMATIN 3D LANDSCAPE IN EWING SARCOMA
Stephen Lessnick
Favorite
Lewis, Valerae

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Valerae Lewis
Favorite
Light, Nicholas

University of Toronto
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Nicholas Light
Favorite
Li, haocheng

3. Department of Mathematics and Statistics, University of Calgary,
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
haocheng Li
Favorite
Li, Li

Huntsman Cancer Institute
Paper 16 - EWSR1:ATF1 BINDS PROMOTER AND ENHANCER REGIONS TO REPROGRAM TRANSCRIPTION IN CLEAR CELL SARCOMA
Li Li
Favorite
Lim, Abner

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Abner Lim
Favorite
Lim, Allison

SpringWorks Therapeutics
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Allison Lim
Favorite
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Allison Lim
Favorite
Lim, Boon Yee

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Boon Yee Lim
Favorite
Lim, Jing Quan

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Jing Quan Lim
Favorite
Lim, Terry

Monash University
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Terry Lim
Favorite
Linardic, Corinne

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Corinne Linardic
Favorite
Linde, Nina

The healthcare business of Merck KGaA
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Nina Linde
Favorite
Lindsay, Daniel

Royal National Orthopaedic Hospital NHS Trust
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Daniel Lindsay
Favorite
Lindsay, Sarah

Oregon Health & Science University
Paper 84 - NATURAL LANGUAGE PROCESSING OF PATHOLOGY REPORTS IDENTIFIES SOFT TISSUE SARCOMAS MISSED BY INTERNATIONAL CLASSIFICATION OF DISEASES CODES IN THE VA NATIONAL DATABASE
Sarah Lindsay
Favorite
Lin, Feng

Daiichi Sankyo, Inc.
Paper 87 - PATIENT-REPORTED SYMPTOM IMPROVEMENT IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR: A CROSS-SECTIONAL SURVEY IN THE UNITED STATES
Feng Lin
Favorite
Lin, Heather

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Heather Lin
Favorite
Lin, Patrick

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Patrick Lin
Favorite
Liu, Stephen V

Georgetown University Medical Center
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Stephen V Liu
Favorite
Livingston, J. Andrew

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
J. Andrew Livingston
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
J. Andrew Livingston
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
J. Andrew Livingston
Favorite
Li, Zhimei

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Zhimei Li
Favorite
Lock, Richard

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Richard Lock
Favorite
Loh, Jui Wan

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Jui Wan Loh
Favorite
Longhi, Alessandra

Rizzoli Orthopedic Institute IRCCS
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Alessandra Longhi
Favorite
Loong, Herbert

The Chinese University of Hong Kong
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Herbert Loong
Favorite
Lopez Lopez, Victor

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Victor Lopez Lopez
Favorite
Lopez-Sanchez, Andres

HCU VIRGEN ARRIXACA
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Andres Lopez-Sanchez
Favorite
LoRusso, Patricia

Yale University School of Medicine, Yale Cancer Center
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Patricia LoRusso
Favorite
Ludwig, Joseph

The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Joseph Ludwig
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Joseph Ludwig
Favorite
Luksch, Roberto

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Roberto Luksch
Favorite
Lundberg, Meijun Z.

Brigham and Women’s Hospital
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Meijun Z. Lundberg
Favorite
Luo, Lixia

Duke University
Paper 30 - SUCCESS AND CHALLENGES OF GENERATING A GENETICALLY ENGINEERED MOUSE MODEL OF CIC-DUX4 SARCOMA
Lixia Luo
Favorite
M
Maciver, Allison

London Health Sciences Centre
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Allison Maciver
Favorite
MacLeod, A Robert

Ionis Pharmaceuticals
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
A Robert MacLeod
Favorite
Madison, Cecelia

Portland VA Medical Center
Paper 84 - NATURAL LANGUAGE PROCESSING OF PATHOLOGY REPORTS IDENTIFIES SOFT TISSUE SARCOMAS MISSED BY INTERNATIONAL CLASSIFICATION OF DISEASES CODES IN THE VA NATIONAL DATABASE
Cecelia Madison
Favorite
Maggiotto, Amanda

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Amanda Maggiotto
Favorite
Mahrous, Ahmed

University Hospitals Bristol NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Ahmed Mahrous
Favorite
Maier, Rebecca

Newcastle University
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Rebecca Maier
Favorite
Maitituoheti, Mayinuer

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Mayinuer Maitituoheti
Favorite
Makanji, Rikesh

Moffitt
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Rikesh Makanji
Favorite
Maki, Robert

Abramson Cancer Center
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Robert Maki
Favorite
Maleddu, Alessandra

University of Colorado Anschutz Medical Campus
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Alessandra Maleddu
Favorite
Maliakal, Pius

PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Pius Maliakal
Favorite
Malik, Hassan

Aintree University Hospital
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Hassan Malik
Favorite
Malkin, David

The Hospital for Sick Children
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
David Malkin
Favorite
Mammen, Joshua

University of Nebraska
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Joshua Mammen
Favorite
Mansfield, David

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
David Mansfield
Favorite
Marec-Berard, Perrine

Ihope
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Perrine Marec-Berard
Favorite
Mariño-Enríquez, Adrian

Brigham and Women’s Hospital
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Adrian Mariño-Enríquez
Favorite
Marritt, Kayla

University of Calgary
Paper 56 - STING ACTIVATION AS AN IMMUNOGENIC THERAPY FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Kayla Marritt
Favorite
Martínez, Jerónimo

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Jerónimo Martínez
Favorite
Martín-Broto, Javier

Fundacíon Jiménez Díaz University Hospital, ATBSARC lab in General Hospital of Villalba, IIS-FJD, Madrid, Spain
Session 1: Telemedicine, Virtual Tumor Boards and Multidisciplinary Care
Location: VCC, East Exhibition Hall A
Javier Martín-Broto
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Javier Martín-Broto
Favorite
Martindale, Moriah

Memorial Sloan Kettering Cancer Center
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Moriah Martindale
Favorite
MArtinez Said, HECTOR

National Cancer Institute Mexico National Cancer Institute
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
HECTOR MArtinez Said
Favorite
Martin, Karla

National Cancer Institute Mexico
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Karla Martin
Favorite
Marusyk, Andriy

Moffitt
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Andriy Marusyk
Favorite
Mascarenhas, Leo

Children's Hospital Los Angeles, University of Southern California Keck School of Medicine
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Leo Mascarenhas
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Leo Mascarenhas
Favorite
Paper 50 - OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE SARCOMA COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Leo Mascarenhas
Favorite
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Leo Mascarenhas
Favorite
Mata, Cristina

Hospital General Universitario Gregorio Marañón
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Cristina Mata
Favorite
Mate, Kedar

McGill University Health Centre
Paper 85 - MEANINGFUL INTERPRETATION OF TORONTO EXTREMITY SALVAGE SCORE IN PEOPLE WITH SOFT-TISSUE SARCOMA USING RASCH ANALYSIS
Kedar Mate
Favorite
Matter, Maurice

Centre Hospitalier Universitaire Vaudois
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Maurice Matter
Favorite
Matusiak, Magdalena

Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Magdalena Matusiak
Favorite
Ma, Yan

Duke University
Paper 30 - SUCCESS AND CHALLENGES OF GENERATING A GENETICALLY ENGINEERED MOUSE MODEL OF CIC-DUX4 SARCOMA
Yan Ma
Favorite
Mayoh, Chelsea

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Chelsea Mayoh
Favorite
Mayo, Nancy

McGill University Health Centre
Paper 85 - MEANINGFUL INTERPRETATION OF TORONTO EXTREMITY SALVAGE SCORE IN PEOPLE WITH SOFT-TISSUE SARCOMA USING RASCH ANALYSIS
Nancy Mayo
Favorite
McAllister-Lucas, Linda

Department of Pediatrics, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Linda McAllister-Lucas
Favorite
McAlpine, Cheryl

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Cheryl McAlpine
Favorite
McCabe, Martin

University of Manchester
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Martin McCabe
Favorite
McCall, David

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
David McCall
Favorite
McHugh, K

Department of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
K McHugh
Favorite
McLatchie, Alex

University College London Cancer Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Alex McLatchie
Favorite
McMonagle, Lisa-Marie

Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Lisa-Marie McMonagle
Favorite
Medina Rodríguez, Laura

Unidad de Gestión Clínica Intercentros de Oncología Médica. Hospitales Universitarios Regional y Virgen de la Victoria. Málaga.
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Laura Medina Rodríguez
Favorite
Meetings, CTOS
CTOS Business Meeting
Location: VCC, East Exhibition Hall A
CTOS Meetings
Favorite
SARC Meeting
Location: VCC, East Exhibition Hall A
CTOS Meetings
Favorite
SELNET Meeting
Location: VCC, East Meeting Room 8
CTOS Meetings
Favorite
TARPSWG Meeting
Location: VCC, East Meeting Room 8
CTOS Meetings
Favorite
Ultra-Rare Sarcoma Meeting
Location: VCC, East Meeting Room 8
CTOS Meetings
Favorite
Meijer, Debora

Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Debora Meijer
Favorite
Melcher, Alan

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Alan Melcher
Favorite
Mendes, Elizabeth

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Elizabeth Mendes
Favorite
Merks, J.H.M.

Princess Máxima Center for Pediatric Oncology
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
J.H.M. Merks
Favorite
Merlini, Alessandra

Department of Oncology, University of Turin
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Alessandra Merlini
Favorite
Merriam, Priscilla

Dana-Farber Cancer Institute
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Priscilla Merriam
Favorite
Merry, Eve

University College London Hospital NHS Foundation Trust
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Eve Merry
Favorite
Mertens, Fredrik

Lund University
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Fredrik Mertens
Favorite
Mesko, Nathan

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Nathan Mesko
Favorite
Messiou, Christina

The Royal Marsden NHS Trust
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Christina Messiou
Favorite
Meurgey, Alexandra

Department of Pathology, Centre Léon Bérard
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Alexandra Meurgey
Favorite
Meyer, Christian

Johns Hopkins Sidney Kimmel Cancer Center
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Christian Meyer
Favorite
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Christian Meyer
Favorite
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Christian Meyer
Favorite
Meyers, Paul

Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Paul Meyers
Favorite
Miah, Aisha

The Royal Marsden NHS Foundation Trust
Session 6: Radiation Oncology & Oligometastatic Disease
Location: VCC, East Exhibition Hall A
Aisha Miah
Favorite
Paper 40 - PRIMARY CARDIAC AND GREAT VESSEL SARCOMAS: MULTI-MODALITY MANAGEMENT AND CLINICAL OUTCOMES AT THE ROYAL MARSDEN HOSPITAL 1987-2021
Aisha Miah
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Aisha Miah
Favorite
Miceli, Rosalba

Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Rosalba Miceli
Favorite
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Rosalba Miceli
Favorite
Michelagnoli, Maria

Sarcoma Department, University College London Hospital
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Maria Michelagnoli
Favorite
Mihai, Radu

Oxford University Hospital NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Radu Mihai
Favorite
Miller, Benjamin

University of Iowa
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Benjamin Miller
Favorite
Miller, Colin

Washington University in St. Louis
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Colin Miller
Favorite
Miller, David T

Division of Genetics and Genomics, Boston Children’s Hospital
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
David T Miller
Favorite
Minard - Colin, Veronique

Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Veronique Minard - Colin
Favorite
Moalla, S.

Department of Imaging, Institut Gustave Roussy
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
S. Moalla
Favorite
Moertel, Christopher

University of Minnesota
Paper 29 - ALTERED EPIGENETIC HOMEOSTASIS YIELDS THERAPEUTIC VULNERABILITIES IN NEUROFIBROMATOSIS TYPE 1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Christopher Moertel
Favorite
Mohammed, Kabir

The Royal Marsden NHS Foundation Trust
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Kabir Mohammed
Favorite
Mohler, David

Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
David Mohler
Favorite
Montoya, Denisse

The Life Raft Group
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Denisse Montoya
Favorite
Monument, Michael

University of Calgary McCaig Bone and Joint Institute
Paper 56 - STING ACTIVATION AS AN IMMUNOGENIC THERAPY FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Michael Monument
Favorite
Moody, Stephanie

PharPoint Research
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Stephanie Moody
Favorite
Moon, Bryan

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Bryan Moon
Favorite
Morales, Analie

University College London Hospital NHS Foundation Trust
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Analie Morales
Favorite
Morgan, Jeffrey

Dana-Farber Cancer Institute
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Jeffrey Morgan
Favorite
Morilla, Joseph

The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Joseph Morilla
Favorite
Morosi, Carlo

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Carlo Morosi
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Carlo Morosi
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Carlo Morosi
Favorite
Morris, Aidan

BC Cancer
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Aidan Morris
Favorite
Moser, Justin

HonorHealth Research and Innovation Institute
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Justin Moser
Favorite
Mottard, Sophie

CIUSSS de l'ESt-de-l'Île-de-Montreal
Session 11: Surgery (Orthopedic, Reconstructive)
Location: VCC, East Exhibition Hall A
Sophie Mottard
Favorite
Paper 05 - MUSCULOSKELETAL ONCOLOGY: PATIENT TRIAGE AND MANAGEMENT DURING THE COVID-19 PANDEMIC
Sophie Mottard
Favorite
Mukherjee, Elina

Department of Pediatrics, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Elina Mukherjee
Favorite
Mullinax, John

Moffitt Cancer Center
Session 9: Immunology & Immunotherapy
Location: VCC, East Exhibition Hall A
John Mullinax
Favorite
Munot, Pritesh

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Pritesh Munot
Favorite
Murphy, Erin

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Erin Murphy
Favorite
N
Nacev, Benjamin

University of Pittsburgh, UPMC Hillman Cancer Center
Session 2: Sarcoma Biology & 'omics
Location: VCC, East Exhibition Hall A
Benjamin Nacev
Favorite
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Benjamin Nacev
Favorite
Nadel, Helen

Stanford Children's Health
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Helen Nadel
Favorite
Nagasubramanian, Ramamoorthy

Nemours Children's Hospital
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Ramamoorthy Nagasubramanian
Favorite
Nahmani, S.

Paediatric Radiology Department, AP-HP, Hôpital Necker Enfants Malades, Université de Paris
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
S. Nahmani
Favorite
Naidoo, Revashnee

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Revashnee Naidoo
Favorite
Napolitano, Andrea

The Royal Marsden NHS Foundation Trust
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Andrea Napolitano
Favorite
Navenot, Jean-Marc

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Jean-Marc Navenot
Favorite
Neilson, John

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
John Neilson
Favorite
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
John Neilson
Favorite
Nenclares, Pablo

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Pablo Nenclares
Favorite
Nessim, Carolyn

University of Ottawa
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Carolyn Nessim
Favorite
Newton, Caroline

Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Caroline Newton
Favorite
Ng, Cedric

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Cedric Ng
Favorite
Ng, Deanna

University of Toronto
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Deanna Ng
Favorite
Nguyen, Sa

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Sa Nguyen
Favorite
Nicholls, Wayne

Queensland Children’s Hospital
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Wayne Nicholls
Favorite
Nielsen, Torsten

Department of Pathology, VGH
Session 12: Desmoid Fibromatosis
Location: VCC, East Exhibition Hall A
Torsten Nielsen
Favorite
Session 5: Diagnostic Advances (Radiology, Pathology, Molecular)
Location: VCC, East Exhibition Hall A
Torsten Nielsen
Favorite
Session 8: Adolescent & Young Adult Sarcoma
Location: VCC, East Exhibition Hall A
Torsten Nielsen
Favorite
Niethard, Maya

Helios Klinikum Berlin-Buch
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Maya Niethard
Favorite
Nishida, Yoshihiro

Nagoya University Hospital
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Yoshihiro Nishida
Favorite
Niziolek, Paul

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Paul Niziolek
Favorite
Nizri, Eran

Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Eran Nizri
Favorite
Norenberg, Ricarda

Chrestos Concept GmbH & Co. KG
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Ricarda Norenberg
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Ricarda Norenberg
Favorite
Noronha, Vanita

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Vanita Noronha
Favorite
Norry, Elliot

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Elliot Norry
Favorite
Noujaim, Jonathan

Maisonneuve-Rosemont Hospital
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Jonathan Noujaim
Favorite
Novak, Marko

Department of Surgical Oncology, Institute of Oncology Ljubliana
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Marko Novak
Favorite
Novotny, Jan Philipp

Brigham and Women's Hospital
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Jan Philipp Novotny
Favorite
Nysom, Karsten

University Hospital Rigshospitalet
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Karsten Nysom
Favorite
Nystrom, Luke

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Luke Nystrom
Favorite
O
O’Keefe, Kylie

PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Kylie O’Keefe
Favorite
Ocejo Gallegos, Jesús Antonio

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Jesús Antonio Ocejo Gallegos
Favorite
O'Day, Steven

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Steven O'Day
Favorite
O'Donohue, Tara

Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Tara O'Donohue
Favorite
Oike, Naoki

Niigata University
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Naoki Oike
Favorite
Okuno, Scott

Mayo Clinic
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Scott Okuno
Favorite
Olofsson Bagge, Roger

Sahlgrenska University Hospital
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Roger Olofsson Bagge
Favorite
Olshinka, Noam

Hadassah university medical center
Paper 05 - MUSCULOSKELETAL ONCOLOGY: PATIENT TRIAGE AND MANAGEMENT DURING THE COVID-19 PANDEMIC
Noam Olshinka
Favorite
Olson, Adam

Department of Radiation Oncology, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Adam Olson
Favorite
Olszanski, Anthony

Johns Hopkins Sidney Kimmel Cancer Center
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Anthony Olszanski
Favorite
Ong, Choon Kiat

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Choon Kiat Ong
Favorite
Orbach, Daniel

SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Institut Curie and Paris Sciences et Lettres
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Daniel Orbach
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Daniel Orbach
Favorite
Ording Müller, LS

Department of Radiology and Intervention Unit for Paediatric Radiology, Oslo University Hospital
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
LS Ording Müller
Favorite
O'Regan, Luke

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Luke O'Regan
Favorite
Oristian, Kristianne

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Kristianne Oristian
Favorite
Paper 30 - SUCCESS AND CHALLENGES OF GENERATING A GENETICALLY ENGINEERED MOUSE MODEL OF CIC-DUX4 SARCOMA
Kristianne Oristian
Favorite
Ortuzar Feliu, Waldo

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Waldo Ortuzar Feliu
Favorite
Osborne, Stuart

F. Hoffmann-La Roche Ltd
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Stuart Osborne
Favorite
Ostwal, Vikas

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Vikas Ostwal
Favorite
O'Sullivan, Maureen

Children's Health Ireland at Crumlin & Trinity College Dublin
Mentorship Session 8: How to Get Involved in CTOS
Maureen O'Sullivan
Favorite
Ovrebo, Kjell

TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Kjell Ovrebo
Favorite
Oza, Jay

Dana Farber Cancer Institute
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Jay Oza
Favorite
Ozenberger, Benjamin

Huntsman Cancer Institute
Paper 16 - EWSR1:ATF1 BINDS PROMOTER AND ENHANCER REGIONS TO REPROGRAM TRANSCRIPTION IN CLEAR CELL SARCOMA
Benjamin Ozenberger
Favorite
P
Pace, E

Department of Radiology, The Royal Marsden NHS Foundation Trust
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
E Pace
Favorite
Palassini, Elena

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Elena Palassini
Favorite
Palmerini, Emanuela

IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
Session 14: Bone Sarcomas
Location: VCC, East Exhibition Hall A
Emanuela Palmerini
Favorite
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Emanuela Palmerini
Favorite
Palmer, Joshua

The James Cancer Hospital at the Ohio State University
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Joshua Palmer
Favorite
Pal, Rajesh

Precision Sarcoma Research Group
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Rajesh Pal
Favorite
Pan, Irene

United BioSource LLC
Paper 87 - PATIENT-REPORTED SYMPTOM IMPROVEMENT IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR: A CROSS-SECTIONAL SURVEY IN THE UNITED STATES
Irene Pan
Favorite
Pantaleo, Maria

DIMES
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Maria Pantaleo
Favorite
Pappo, Alberto

Department of Oncology, St. Jude Children's Research Hospital
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Alberto Pappo
Favorite
Park, Peter J

Department of Biomedical Informatics, Harvard Medical School
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Peter J Park
Favorite
Partington, Karen

Oxford University Hospital NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Karen Partington
Favorite
Pasquali, Sandro

Molecular Pharmacology Unit, Department of Research and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Sandro Pasquali
Favorite
Patel, Jaymin
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Jaymin Patel
Favorite
Patel, Manish R.

Sarah Cannon Research Institute, Florida Cancer Specialists & Research Institute
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Manish R. Patel
Favorite
Patel, Shreyaskumar

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Shreyaskumar Patel
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Shreyaskumar Patel
Favorite
Patil, Vijay

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Vijay Patil
Favorite
Patin, Emmanuel

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Emmanuel Patin
Favorite
Pawel, Bruce

Children's Hospital Los Angeles
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Bruce Pawel
Favorite
Pedersen, Malin

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Malin Pedersen
Favorite
Percio, Stefano

Fondazione IRCCS Istituto Nazionale Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Stefano Percio
Favorite
Perhavec, Andraz

Institute of Oncology Ljubljana
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Andraz Perhavec
Favorite
Periyapatna, Nivitha

University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Nivitha Periyapatna
Favorite
Perkins, Susan

Indiana University Department of Biostatistics and Health Data Science
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Susan Perkins
Favorite
Perreault, Sébastien

Department of Neurosciences, CHU Sainte Justine
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Sébastien Perreault
Favorite
Perrone, Federica

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Federica Perrone
Favorite
Pestana, Roberto

Hospital Israelita Albert Einstein
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Roberto Pestana
Favorite
Peterfy, Charles

Spire Sciences, Boca Raton, FL, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Charles Peterfy
Favorite
Petersen, Ivy

Mayo Clinic
Paper 39 - PENCIL BEAM SCANNING PROTON RADIOTHERAPY FOR SACRAL CHORDOMAS: THE MAYO CLINIC EXPERIENCE
Ivy Petersen
Favorite
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Ivy Petersen
Favorite
Peterson, Nicholas

University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Nicholas Peterson
Favorite
Peul, Wilco

University Neurosurgical Centre Holland, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Wilco Peul
Favorite
Phillips, Marianne

Perth Children's Hospital
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Marianne Phillips
Favorite
Piculell, Katherine

Division of Genetics and Genomics, Boston Children’s Hospital
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Katherine Piculell
Favorite
Pierron, Gaelle

Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Gaelle Pierron
Favorite
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Gaelle Pierron
Favorite
Pilco-Janeta, Daniel F.

Brigham and Women's Hospital
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Daniel F. Pilco-Janeta
Favorite
Pillay, Nischalan

University College London and Royal National Orthopaedic Hospital
Session 5: Diagnostic Advances (Radiology, Pathology, Molecular)
Location: VCC, East Exhibition Hall A
Nischalan Pillay
Favorite
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Nischalan Pillay
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Nischalan Pillay
Favorite
Podleska, Lars

Essen University Hospital
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Lars Podleska
Favorite
Polak, Samuel

University Neurosurgical Centre Holland, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Samuel Polak
Favorite
Poole, Bella

Moffitt
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Bella Poole
Favorite
Poppe, Matthew

University of Utah Huntsman Cancer Institute
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Matthew Poppe
Favorite
Porfilio, Timothy

Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Timothy Porfilio
Favorite
Porpiglia, Andrea

Fox Chase Cancer Center
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Andrea Porpiglia
Favorite
Posey, Kristi

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Kristi Posey
Favorite
Poultsides, George

Stanford
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
George Poultsides
Favorite
Prabhash, Kumar

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Kumar Prabhash
Favorite
Principe, Miguel Alfonso

Lunenfeld-Tanenbaum Research Institute
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Miguel Alfonso Principe
Favorite
Prochazka, Patrick

Duke University School of Medicine
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Patrick Prochazka
Favorite
Prologo, David J

Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
David J Prologo
Favorite
Proszek, Paula

Clinical Genomics Translational Research, Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Paula Proszek
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Paula Proszek
Favorite
Provenzano, Salvatore

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Salvatore Provenzano
Favorite
Przybyl, Joanna

McGill University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Joanna Przybyl
Favorite
Puertas, Pablo

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Pablo Puertas
Favorite
Q
Qian, Meng

Daiichi Sankyo, Inc, Basking Ridge, NJ, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Meng Qian
Favorite
Quaglietta, L.

Division of Oncology, Santobono-Pausilipon Children's Hospital
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
L. Quaglietta
Favorite
Quagliuolo, Vittorio

Istituto Clinico Humanitas
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Vittorio Quagliuolo
Favorite
Qumseya, Amira

COG Data Center, University of Florida
Paper 50 - OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE SARCOMA COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Amira Qumseya
Favorite
R
Radaelli, Stefano

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Stefano Radaelli
Favorite
Ragbir, Maniram

The Newcastle upon Tyne NHS Hospitals Foundation Trust
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Maniram Ragbir
Favorite
Rai, Kunal

The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Kunal Rai
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Kunal Rai
Favorite
Ramtohul, Toulsie

Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Toulsie Ramtohul
Favorite
Randall, Lor

University of California, Davis/Orthopaedic Surgery
Paper 31 - ENGINEERED BONE MARROW: A COMPLEX MODEL FOR PRIMARY OSTEOSARCOMA TUMORIGENESIS
Lor Randall
Favorite
Rangan, Amar

University of York
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Amar Rangan
Favorite
Rankin, Kenneth

North of England Bone and Soft Tissue Tumour Service, Newcastle upon Tyne Hospitals NHS Foundation Trust and Translational and Clinical Research Institute, Newcastle University, UK
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Kenneth Rankin
Favorite
Rastogi, Sameer

TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Sameer Rastogi
Favorite
Rastrelli, Marco

Istituto Oncologico Veneto - IOV
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Marco Rastrelli
Favorite
Ratan, Ravin

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Ravin Ratan
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Ravin Ratan
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Ravin Ratan
Favorite
Raut, Chandrajit

Brigham and Women’s Hospital/Harvard Medical School
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Chandrajit Raut
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Chandrajit Raut
Favorite
Rawal, Bhupendra

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Bhupendra Rawal
Favorite
Ray-Coquard, Isabelle

Department of Medical Oncology, Centre Léon Bérard,
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Isabelle Ray-Coquard
Favorite
Raymond, Daniel

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Daniel Raymond
Favorite
Raza, Shaan

MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Shaan Raza
Favorite
Reddy, Vishruth

University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Vishruth Reddy
Favorite
Reed, Damon

Moffitt Cancer Center
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Damon Reed
Favorite
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Damon Reed
Favorite
Reichardt, Peter

Helios Klinikum Berlin-Buch
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Peter Reichardt
Favorite
Reijers, Sophie

Nederlands Cancer Institute
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Sophie Reijers
Favorite
Reinecke, James

Nationwide Children's Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
James Reinecke
Favorite
Reinke, Denise

University of Michigan Comprehensive Cancer Center
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Denise Reinke
Favorite
Reith, John

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
John Reith
Favorite
Rekhi:, Bharat

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Bharat Rekhi:
Favorite
Rerko, Matthew

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Matthew Rerko
Favorite
Restrepo Lopez, Juliana

Clínica Vida Fundación and Clínica de Oncología Astorga
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Juliana Restrepo Lopez
Favorite
Rickard, Rory

University Hospital Plymouth NHS Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Rory Rickard
Favorite
Riedel, Richard

Duke Cancer Institute, Duke University Medical Center
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Richard Riedel
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Richard Riedel
Favorite
Rippe, Karsten

Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Karsten Rippe
Favorite
Roberts, James

University College London Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
James Roberts
Favorite
Robertson-Tessi, Mark

Moffitt Cancer Center
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Mark Robertson-Tessi
Favorite
Roberts, Ryan

Division of Hematology and Oncology, Nationwide Children’s Hospital, Department of Pediatrics, The Ohio State University Wexner College of Medicine
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Ryan Roberts
Favorite
Robinson, Steven

Mayo Clinic
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Steven Robinson
Favorite
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Steven Robinson
Favorite
Roelands, Jessica

Department of Pathology, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Jessica Roelands
Favorite
Roggin, Kevin

University of Chicago
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
Kevin Roggin
Favorite
Roland, Christina

University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Christina Roland
Favorite
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Christina Roland
Favorite
Rompou, Vaia

The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Vaia Rompou
Favorite
Rose, Brandon

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Brandon Rose
Favorite
Rosenthal, Katherine

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Katherine Rosenthal
Favorite
Rose, Peter

Mayo Clinic
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Peter Rose
Favorite
Roshal, Anna

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Anna Roshal
Favorite
Roszik, Jason

The University of Texas MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Jason Roszik
Favorite
Roulstone, Victoria

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Victoria Roulstone
Favorite
Rubin, Brian

Cleveland Clinic
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Brian Rubin
Favorite
Rubino, Franco

MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Franco Rubino
Favorite
Rullan, Antonio

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Antonio Rullan
Favorite
Rushing, Daniel

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Daniel Rushing
Favorite
Rutkowski, Piotr

Department of Soft Tissue/Bone Sarcoma and Melanoma; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Piotr Rutkowski
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Piotr Rutkowski
Favorite
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Piotr Rutkowski
Favorite
Rutkowski, Piotr

Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Piotr Rutkowski
Favorite
Ryan, Christopher

Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Christopher Ryan
Favorite
S
Saini, Sidharth

Toronto General Hospital
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Sidharth Saini
Favorite
Salazar Arcila, Carolina

University of Calgary
Paper 56 - STING ACTIVATION AS AN IMMUNOGENIC THERAPY FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Carolina Salazar Arcila
Favorite
Sanchez Esquer, Ignacio

Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Ignacio Sanchez Esquer
Favorite
Sandven, Ingunn

Oslo University Hospital
Paper 53 - THERE’S NO PLACE LIKE HOME. TREATING ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA AT HOME
Ingunn Sandven
Favorite
Sanfilippo, Roberta

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Roberta Sanfilippo
Favorite
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Roberta Sanfilippo
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Roberta Sanfilippo
Favorite
Sangalli, Claudia

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Claudia Sangalli
Favorite
Saraf, Amanda

Riley Children's Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Amanda Saraf
Favorite
Sarre, Catherine

TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Catherine Sarre
Favorite
Satcher, Robert

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Robert Satcher
Favorite
Savjani, Ricky

University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Ricky Savjani
Favorite
Sayyed, Raza

The Royal Marsden Hospital
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Raza Sayyed
Favorite
Sayyed, Raza

The Royal Marsden Hospital NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Raza Sayyed
Favorite
Sayyed, Raza

The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Raza Sayyed
Favorite
Scally, Christopher

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Christopher Scally
Favorite
Schaefer, Inga-Marie

Brigham and Women's Hospital
Diagnostic Advances: Poster Highlights
Inga-Marie Schaefer
Favorite
Liddy Shriver Early Research Award
Location: VCC, East Exhibition Hall A
Inga-Marie Schaefer
Favorite
Scharschmidt, Thomas

Ohio State University Wexner Medical Center
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Thomas Scharschmidt
Favorite
Schneider, Patricia

McMaster University
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Patricia Schneider
Favorite
Schöffski, Patrick

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Patrick Schöffski
Favorite
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Patrick Schöffski
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Patrick Schöffski
Favorite
Schoot, R.A.

Princess Máxima Center for Pediatric Oncology
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
R.A. Schoot
Favorite
Schrage, Yvonne

Netherland Cancer Institute
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Yvonne Schrage
Favorite
Schuetze, Scott

University of Michigan
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Scott Schuetze
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Scott Schuetze
Favorite
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Scott Schuetze
Favorite
Schut, Anne-Rose

Erasmus Medical Center Rotterdam
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Anne-Rose Schut
Favorite
Schwartz, Gary

Columbia University Herbert Irving Comprehensive Cancer Center
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Gary Schwartz
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Gary Schwartz
Favorite
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Gary Schwartz
Favorite
Sciot, Raf

Department of Pathology, KU Leuven and University Hospitals Leuven
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Raf Sciot
Favorite
Scott, Jacob

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Jacob Scott
Favorite
Selich-Anderson, Julia

Abigail Wexner Research Institute at Nationwide Children's Hospital
Paper 95 - STUDYING THE ROLE OF FLI PORTION OF EWS: FLI IN TRANSCRIPTION REGULATION VIA MODULATION OF CHROMATIN 3D LANDSCAPE IN EWING SARCOMA
Julia Selich-Anderson
Favorite
Serrano, César

Vall D'hebron Institute of Oncology
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
César Serrano
Favorite
Serrano, Jonathan

Department of Pathology, New York University Langone Health, Perlutter Cancer Center
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Jonathan Serrano
Favorite
Servois, Vincent

Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Vincent Servois
Favorite
Setty, Bhuvana

Nationwide Children's Hospital
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Bhuvana Setty
Favorite
Shankar, Arjun

University College London Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Arjun Shankar
Favorite
Shepard, Dale

Cleveland Clinic Taussig Cancer Institute
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Dale Shepard
Favorite
Shern, John

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
John Shern
Favorite
Shetty, Nitin

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Nitin Shetty
Favorite
Shirai, Ryota

Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Ryota Shirai
Favorite
Shlien, Adam

Research Institute, The Hospital for Sick Children
Session 2: Sarcoma Biology & 'omics
Location: VCC, East Exhibition Hall A
Adam Shlien
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Adam Shlien
Favorite
Paper 12 - THE DEVELOPMENT OF A MULTISCALE TRANSCRIPTIONAL ATLAS OF SARCOMA
Adam Shlien
Favorite
Shukla, Neerav

Department of Pediatrics, Memorial Sloan Kettering Cancer Center
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Neerav Shukla
Favorite
Shuster, Dale

Daiichi Sankyo, Inc, Basking Ridge, NJ, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Dale Shuster
Favorite
Sicklick, Jason

UC San Diego Health
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Jason Sicklick
Favorite
Sieverling, Lina

Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Lina Sieverling
Favorite
Simmons, Christine

BC Cancer
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Christine Simmons
Favorite
Singer, Samuel

Memorial Sloan Kettering Cancer Center
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Samuel Singer
Favorite
Singh, Arun

University of California at Los Angeles
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Arun Singh
Favorite
Singh, Reena

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Reena Singh
Favorite
Siontis, Brittany

Mayo Clinic
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Brittany Siontis
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Brittany Siontis
Favorite
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Brittany Siontis
Favorite
Siu, Lillian

Princess Margaret Cancer Centre, University Health Network
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Lillian Siu
Favorite
Skoczylas, Jacek

TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Jacek Skoczylas
Favorite
Slawaska-Eng, David

McMaster University
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
David Slawaska-Eng
Favorite
Sleijfer, Stefan

Erasmus Medical Center Rotterdam
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Stefan Sleijfer
Favorite
Slotkin, Emily

Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Emily Slotkin
Favorite
SMADJA, Jeremy

Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Jeremy SMADJA
Favorite
Smith, Henry

Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Henry Smith
Favorite
Smith, L. Mary

SpringWorks Therapeutics
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
L. Mary Smith
Favorite
Smith, Myles

Sarcoma Unit, Royal Marsden Hospital
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Myles Smith
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Myles Smith
Favorite
Snow, Hayden

Peter MacCallum Cancer Centre
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Hayden Snow
Favorite
Snuderl, Matija

Department of Pathology, New York University Langone Health, Perlutter Cancer Center
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Matija Snuderl
Favorite
Somaiah, Neeta

The University of Texas MD Anderson Cancer Center
Session 9: Immunology & Immunotherapy
Location: VCC, East Exhibition Hall A
Neeta Somaiah
Favorite
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Neeta Somaiah
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Neeta Somaiah
Favorite
Sorensen, Poul

University of British Columbia
Herman Suit Lecture: Sarcoma Translocations: Dangerous Liaisons, Or Portals To Improved Diagnostics, New Biology, And Targeted Therapeutics
Location: VCC, East Exhibition Hall A
Poul Sorensen
Favorite
Spargo, Sarah

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Sarah Spargo
Favorite
Spierenburg, Geert

Leiden University Medical Center
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Geert Spierenburg
Favorite
Srinivas, Sujay

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Sujay Srinivas
Favorite
Stacchiotti, Silvia

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Mentorship Session 6: Wellness/Work Life Balance
Silvia Stacchiotti
Favorite
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Silvia Stacchiotti
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Silvia Stacchiotti
Favorite
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Silvia Stacchiotti
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Silvia Stacchiotti
Favorite
Stas, Marguerite

Universitair Ziekenhuis Leuven
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Marguerite Stas
Favorite
Steeghs, Neeltje

The Netherlands Cancer Institute
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Neeltje Steeghs
Favorite
Steele, Christopher D

Research Department of Pathology, University College London Cancer Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Christopher D Steele
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Christopher D Steele
Favorite
Steffner, Robert

Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Robert Steffner
Favorite
Stethen, Taylor

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Taylor Stethen
Favorite
Steuer, Conor

Winship Cancer Institute, Emory University School of Medicine
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Conor Steuer
Favorite
Storhaug, Gudveig

Oslo University Hospital
Paper 53 - THERE’S NO PLACE LIKE HOME. TREATING ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA AT HOME
Gudveig Storhaug
Favorite
Strauss, Dirk

Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Dirk Strauss
Favorite
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Dirk Strauss
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Dirk Strauss
Favorite
Strauss, Sandra

University College, London
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Sandra Strauss
Favorite
Strauss, Sandra

Sarcoma Department, University College Hospital, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Sandra Strauss
Favorite
Subbiah, Vivek

The University of Texas MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Vivek Subbiah
Favorite
Sulciner, Megan

Brigham and Women's Hospital/Harvard Medical School
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Megan Sulciner
Favorite
Sundby, Taylor

National Cancer Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Taylor Sundby
Favorite
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Taylor Sundby
Favorite
Surdez, Didier

Institut Curie Research Center
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Didier Surdez
Favorite
Sutton, Thomas

Oregon Health and Science University
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Thomas Sutton
Favorite
Swallow, Carol

University of Toronto
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Carol Swallow
Favorite
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Carol Swallow
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Carol Swallow
Favorite
Szymanski, Jeffrey J

Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Jeffrey J Szymanski
Favorite
T
Tabone, Severine

centre léon Berad
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Severine Tabone
Favorite
Tann, Mark

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Mark Tann
Favorite
Tao, Ben

Daiichi Sankyo, Inc.
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Ben Tao
Favorite
Tao, Derrick L.

The University of Texas MD Anderson Cancer Center
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Derrick L. Tao
Favorite
Tap, William

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
William Tap
Favorite
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
William Tap
Favorite
Paper 87 - PATIENT-REPORTED SYMPTOM IMPROVEMENT IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR: A CROSS-SECTIONAL SURVEY IN THE UNITED STATES
William Tap
Favorite
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
William Tap
Favorite
Tarabichi, Maxime

Francis Crick Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Maxime Tarabichi
Favorite
Taslim, Cenny

nationwide childrens hospital
Paper 95 - STUDYING THE ROLE OF FLI PORTION OF EWS: FLI IN TRANSCRIPTION REGULATION VIA MODULATION OF CHROMATIN 3D LANDSCAPE IN EWING SARCOMA
Cenny Taslim
Favorite
Teh, Bin Tean

National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Bin Tean Teh
Favorite
ter Horst, S.A.J.

Department of Radiology and Nuclear Medicine, Wilhelmina Children’s Hospital University Medical Centre Utrecht
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
S.A.J. ter Horst
Favorite
Terezakis, Stephanie

University of Minnesota
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Stephanie Terezakis
Favorite
Teufel, Michael

Boehringer Ingelheim Pharmaceuticals, Inc.
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Michael Teufel
Favorite
Thomas, Jacob

University of Southern California Norris Comprehensive Cancer Center
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Jacob Thomas
Favorite
Thomas, Stephanie

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Stephanie Thomas
Favorite
Paper 50 - OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE SARCOMA COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Stephanie Thomas
Favorite
Thorpe, Steven

University of California, Davis/Orthopaedic Surgery
Paper 31 - ENGINEERED BONE MARROW: A COMPLEX MODEL FOR PRIMARY OSTEOSARCOMA TUMORIGENESIS
Steven Thorpe
Favorite
Thway, Khin

The Royal Marsden NHS Foundation Trust
Paper 40 - PRIMARY CARDIAC AND GREAT VESSEL SARCOMAS: MULTI-MODALITY MANAGEMENT AND CLINICAL OUTCOMES AT THE ROYAL MARSDEN HOSPITAL 1987-2021
Khin Thway
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Khin Thway
Favorite
Tibbits, Justin

University of Minnesota
Paper 29 - ALTERED EPIGENETIC HOMEOSTASIS YIELDS THERAPEUTIC VULNERABILITIES IN NEUROFIBROMATOSIS TYPE 1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Justin Tibbits
Favorite
Timbergen, Milea J.M.

Erasmus Medical Center Rotterdam
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Milea J.M. Timbergen
Favorite
Tinoco, Gabriel

The Ohio State University Comprehensive Cancer Center
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Gabriel Tinoco
Favorite
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Gabriel Tinoco
Favorite
Tirotta, Fabio

University Hospitals Birmingham NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Fabio Tirotta
Favorite
Tirunagaru, Vijaya G.

Rain Therapeutics, Inc.
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Vijaya G. Tirunagaru
Favorite
Titus, Mark

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Mark Titus
Favorite
Tokson, Jacqueline Hart

Huntsman Cancer Institute
Paper 74 - TOTAL SIZE OF POST-OPERATIVE SEROMA CORRELATES WITH WOUND COMPLICATIONS FOLLOWING SOFT-TISSUE SARCOMA RESECTION
Jacqueline Hart Tokson
Favorite
Tolomeo, Francesco

Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Francesco Tolomeo
Favorite
Toprak, Umut

Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Umut Toprak
Favorite
Torres, Keila

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Keila Torres
Favorite
Tran, Thuy

City of Hope
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
Thuy Tran
Favorite
Trent, Jonathan

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Jonathan Trent
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Jonathan Trent
Favorite
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Jonathan Trent
Favorite
Trepel, Jane

National Cancer Institute
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Jane Trepel
Favorite
Trucco, Matteo

Cleveland Clinic Children's
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Matteo Trucco
Favorite
Truong, Danh

The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Danh Truong
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Danh Truong
Favorite
Truong, Pauline

BC Cancer
Paper 38 - PATIENT OUTCOMES IN METASTATIC EWING SARCOMA RESTRICTED TO PULMONARY METASTASES TREATED WITH WHOLE LUNG RADIATION
Pauline Truong
Favorite
Tseng, Jennifer

University of Chicago
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
Jennifer Tseng
Favorite
Tseng, William

City of Hope National Medical Center
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
William Tseng
Favorite
Tseng, William

City of Hope National Medical Center
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
William Tseng
Favorite
Tsimberidou, Apostolia

The University of Texas MD Anderson Cancer Center
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Apostolia Tsimberidou
Favorite
Tsoi, Kim

Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto
Session 14: Bone Sarcomas
Location: VCC, East Exhibition Hall A
Kim Tsoi
Favorite
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Kim Tsoi
Favorite
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Kim Tsoi
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Kim Tsoi
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Kim Tsoi
Favorite
Tufino, Adriana

Department of Pediatrics, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Adriana Tufino
Favorite
turcotte, robert

McGill University Health Centre
Paper 85 - MEANINGFUL INTERPRETATION OF TORONTO EXTREMITY SALVAGE SCORE IN PEOPLE WITH SOFT-TISSUE SARCOMA USING RASCH ANALYSIS
robert turcotte
Favorite
Turner, Paul

The Newcastle upon Tyne Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Paul Turner
Favorite
Tyrrell, Vanessa

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Vanessa Tyrrell
Favorite
Tzanis, Dimitri

Department of Surgical Oncology, Institut Curie
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Dimitri Tzanis
Favorite
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Dimitri Tzanis
Favorite
U
Ullrich, Nicole J

Department of Neurology, Boston Children’s Hospital
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Nicole J Ullrich
Favorite
Underdown, Mary J

Department of Radiology, University of Colorado School of Medicine - Anschutz Medical Campus
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Mary J Underdown
Favorite
V
Valenzuela, Raul

MDACC
Session 5: Diagnostic Advances (Radiology, Pathology, Molecular)
Location: VCC, East Exhibition Hall A
Raul Valenzuela
Favorite
Valero-Arrese, Lorena

Hospital Universitari Vall d'Hebron
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Lorena Valero-Arrese
Favorite
Valverde Morales, Claudia Maria

Vall D'Hebron University Hospital
Mentorship Session 4: Program Development: Starting Sarcoma Programs to Growing Established Programs
Claudia Maria Valverde Morales
Favorite
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Claudia Maria Valverde Morales
Favorite
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Claudia Maria Valverde Morales
Favorite
van Broekhoven, Danique L.M.

Erasmus Medical Center Rotterdam
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Danique L.M. van Broekhoven
Favorite
van Coevorden, Frits

The Netherlands Cancer Institute
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Frits van Coevorden
Favorite
van Dalen, Thijs

University Medical Center Utrecht
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Thijs van Dalen
Favorite
Van De Rijn, Matt

Stanford University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Matt Van De Rijn
Favorite
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Matt Van De Rijn
Favorite
van de Sande, Michiel

Leiden University Medical Center, Leiden, Netherlands
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Michiel van de Sande
Favorite
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Michiel van de Sande
Favorite
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Michiel van de Sande
Favorite
van Den Akker, Brendy

LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Brendy van Den Akker
Favorite
Van Der Breggen, Ruud

Department of Pathology, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Ruud Van Der Breggen
Favorite
van der Graaf, Winette

Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands
Nina Axelrad Lecture: What is success in the real world of sarcoma?
Location: VCC, East Exhibition Hall A
Winette van der Graaf
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Winette van der Graaf
Favorite
van der Hage, Jos

Department of Surgery, Leiden University Medical Center
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Jos van der Hage
Favorite
van der ploeg, Manon

Department of Pathology, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Manon van der ploeg
Favorite
Van der Wal, Robert

Leiden University Medical center
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Robert Van der Wal
Favorite
van Ewijk, Roelof

Princess Máxima Center for Pediatric Oncology
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Roelof van Ewijk
Favorite
Van Ginkel, Robert J.

Department of Surgical Oncology, University Medical Center Groningen, University of Groningen
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Robert J. Van Ginkel
Favorite
Van Houdt, Winan

The Netherlands Cancer Institute
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Winan Van Houdt
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Winan Van Houdt
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Winan Van Houdt
Favorite
van IJzendoorn, David

Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
David van IJzendoorn
Favorite
van Langevelde, Kirsten

Leiden University Medical Center
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Kirsten van Langevelde
Favorite
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Kirsten van Langevelde
Favorite
Van Loo, Peter

The University of Texas MD Anderson Cancer Center
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Peter Van Loo
Favorite
van Oost, Siddh

Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Siddh van Oost
Favorite
van rijn, Rick

Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Rick van rijn
Favorite
Van Tilburg, Cornelis

Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ)
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Cornelis Van Tilburg
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Cornelis Van Tilburg
Favorite
Van Tine, Brian

Washington University School of Medicine
Mentorship Session 9: How to Get Your Paper Published
Brian Van Tine
Favorite
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Brian Van Tine
Favorite
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Brian Van Tine
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Brian Van Tine
Favorite
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Brian Van Tine
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Brian Van Tine
Favorite
Van Winkle, Erin

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Erin Van Winkle
Favorite
Vanleeuw, Ulla

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Ulla Vanleeuw
Favorite
Varma, Sushama

Stanford University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Sushama Varma
Favorite
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Sushama Varma
Favorite
Vassos, Nikolaos

Mannheim University Medical Center
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Nikolaos Vassos
Favorite
Vatelle, Sophia

Nationwide Children's Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Sophia Vatelle
Favorite
Veli, Mesel

University College Hospital London NHS Foundation Trust
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Mesel Veli
Favorite
Venkatramani, Rajkumar

Baylor College of Medicine
Paper 50 - OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE SARCOMA COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Rajkumar Venkatramani
Favorite
Venkat, Shree

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Shree Venkat
Favorite
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Shree Venkat
Favorite
Vennam, Sujay

Stanford University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Sujay Vennam
Favorite
Verfaillie, Annelien

Francis Crick Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Annelien Verfaillie
Favorite
Verhoef, Cornelis

Erasmus Medical Center
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Cornelis Verhoef
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Cornelis Verhoef
Favorite
Verneris, Michael

Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Michael Verneris
Favorite
Verreet, Jasper

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Jasper Verreet
Favorite
Verret, Benjamin

Institute Gustave Roussy- paris
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Benjamin Verret
Favorite
Vijayakumar, Gayathri

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Gayathri Vijayakumar
Favorite
Villemeur, Marie

Curie institute
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Marie Villemeur
Favorite
Vincenzi, Bruno

Campus Bio-Medico University of Rome
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Bruno Vincenzi
Favorite
Vincenzi, Bruno

Università Campus Bio-Medico di Roma
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Bruno Vincenzi
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Bruno Vincenzi
Favorite
Viskochil, David

Division of Medical Genetics, Huntsman Cancer Institute, University of Utah
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
David Viskochil
Favorite
von Mehren, Margaret

Fox Chase Cancer Center
Mentorship Session 7: How to Deal with Conflict
Margaret von Mehren
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Margaret von Mehren
Favorite
Voss, Rachel

Moffitt Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Rachel Voss
Favorite
Votanopoulos, Konstantinos

Wake Forest
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
Konstantinos Votanopoulos
Favorite
W
Wagner, Andrew

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Andrew Wagner
Favorite
Wagner, Michael

University of Washington/Fred Hutch Cancer Center
Session 3: Medical & Pediatric Oncology and Clinical Trials
Location: VCC, East Exhibition Hall A
Michael Wagner
Favorite
Wahba, Mona

PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Mona Wahba
Favorite
Wahlig, Brian

Mayo Clinic
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Brian Wahlig
Favorite
Walker, Deandra

Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Deandra Walker
Favorite
Walters, Ian

Intensity Therapeutics
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Ian Walters
Favorite
Wang, Jiping

TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Jiping Wang
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Jiping Wang
Favorite
Wang, Qing

Department of Pathology, Institut Claudius Régaud, IUCT-Oncopole, Toulouse,
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Qing Wang
Favorite
Wang, Ruoxi

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Ruoxi Wang
Favorite
Wang, Wei-Lien

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Wei-Lien Wang
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Wei-Lien Wang
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Wei-Lien Wang
Favorite
Wang, Xia

GeneHome, Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Xia Wang
Favorite
Wason, James

Newcastle University
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
James Wason
Favorite
Watowich, Stepahnie

MD Anderson Cancer Center
Paper 88 - A NOVEL CD103+ CDC1 DENDRITIC CELL VACCINE FOR OSTEOSARCOMA
Stepahnie Watowich
Favorite
Watson, Sarah

Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Sarah Watson
Favorite
Watt, Tanya

University of Texas Southwestern Medical Center
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Tanya Watt
Favorite
Weetall, Marla

PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Marla Weetall
Favorite
Weise, Amy

Barbara Ann Karmanos Cancer Institute, Karmanos Cancer Institute
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Amy Weise
Favorite
Weiss, Aaron

Maine Cancer Program
Paper 50 - OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE SARCOMA COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Aaron Weiss
Favorite
Wessel, Lauren

University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Lauren Wessel
Favorite
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Lauren Wessel
Favorite
Westermann, Frank

Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Frank Westermann
Favorite
West, Robert

Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Robert West
Favorite
Westwood, Andrew

Euro Ewing Consortium
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Andrew Westwood
Favorite
Wexler, Leonard

Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Leonard Wexler
Favorite
Whalen, Giles Francis

University of Massachusetts Memorial Medical Center,
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Giles Francis Whalen
Favorite
Wheatley, Keith

University of Birmingham
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Keith Wheatley
Favorite
Whelan, Jeremy

University College London Hospitals
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Jeremy Whelan
Favorite
White, Lawrence

Toronto General Hospital
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Lawrence White
Favorite
Widemann, Brigitte

National Cancer Institute
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Brigitte Widemann
Favorite
Wijers-Koster, Pauline

Department of Pathology, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Pauline Wijers-Koster
Favorite
Wilky, Breelyn

University of Colorado
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Breelyn Wilky
Favorite
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Breelyn Wilky
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Breelyn Wilky
Favorite
Williams, Dennis

Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Dennis Williams
Favorite
Williams, Kyle

Univerysity of Minnesota
Paper 29 - ALTERED EPIGENETIC HOMEOSTASIS YIELDS THERAPEUTIC VULNERABILITIES IN NEUROFIBROMATOSIS TYPE 1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Kyle Williams
Favorite
Windsor, Rachael

Sarcoma Department, University College Hospital, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Rachael Windsor
Favorite
Winstanley, Mark

Starship Children's Hospital
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Mark Winstanley
Favorite
Witt, Russell

University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Russell Witt
Favorite
Wolters, Pamela

National Cancer Institute
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Pamela Wolters
Favorite
Wong, Marie

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Marie Wong
Favorite
Wong, Ralph

Cancer Care Manitoba
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Ralph Wong
Favorite
Wood, Kris

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Kris Wood
Favorite
Wooldridge, Adam

Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Adam Wooldridge
Favorite
Wozniak, Agnieszka

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
Mentorship Session 3: Biobanking and Correlative Science: How to Establish and Learn about Rare Tumor Biology
Agnieszka Wozniak
Favorite
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Agnieszka Wozniak
Favorite
Wu, Chia-Chin

The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Chia-Chin Wu
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Chia-Chin Wu
Favorite
Wunder, Jay

Mount Sinai Hospital; University of Toronto
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Jay Wunder
Favorite
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Jay Wunder
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Jay Wunder
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Jay Wunder
Favorite
Wunker, Claire

Saint Louis University
Paper 32 - ESTABLISHMENT OF HIGH-GRADE SOFT TISSUE SARCOMA METASTATIC DISEASE MURINE MODELS
Claire Wunker
Favorite
Wurtz, Lawrence

Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Lawrence Wurtz
Favorite
X
Xie, Jinhan

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Jinhan Xie
Favorite
Xue, Wei

COG Data and Statistics Center, University of Florida
Paper 50 - OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE SARCOMA COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Wei Xue
Favorite
Xu, Feng

Rain Therapeutics, Inc.
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Feng Xu
Favorite
Xu, Rui-Hua

Sun Yat-sen University Cancer Center
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Rui-Hua Xu
Favorite
Y
Yamamoto, Noboru

Department of Experimental Therapeutics, National Cancer Center Hospital
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Noboru Yamamoto
Favorite
Yang, Yuanzheng

MD Anderson Cancer Center
Paper 88 - A NOVEL CD103+ CDC1 DENDRITIC CELL VACCINE FOR OSTEOSARCOMA
Yuanzheng Yang
Favorite
Yao, Wantong

The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Wantong Yao
Favorite
Yap, Timothy

MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Timothy Yap
Favorite
Yeong, Joe

Institute of Molecular and Cell Biology
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Joe Yeong
Favorite
Ye, Xin

Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Xin Ye
Favorite
Paper 87 - PATIENT-REPORTED SYMPTOM IMPROVEMENT IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR: A CROSS-SECTIONAL SURVEY IN THE UNITED STATES
Xin Ye
Favorite
Yim, Andrew

McGill University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Andrew Yim
Favorite
Yi, Thomas

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Thomas Yi
Favorite
Yushak, Melinda

Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Melinda Yushak
Favorite
Z
Zaffaroni, Nadia

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Nadia Zaffaroni
Favorite
Zahler, Stacey

Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Stacey Zahler
Favorite
Zaidi, Shane

The Royal Marsden Hospital
Paper 40 - PRIMARY CARDIAC AND GREAT VESSEL SARCOMAS: MULTI-MODALITY MANAGEMENT AND CLINICAL OUTCOMES AT THE ROYAL MARSDEN HOSPITAL 1987-2021
Shane Zaidi
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Shane Zaidi
Favorite
Zanframundo, Claudia

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Claudia Zanframundo
Favorite
Zenke, Frank

EMD Serono Inc.
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Frank Zenke
Favorite
Zer, Alona
Session 3: Medical & Pediatric Oncology and Clinical Trials
Location: VCC, East Exhibition Hall A
Alona Zer
Favorite
Zeuner, Harald

F. Hoffmann-La Roche Ltd
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Harald Zeuner
Favorite
Zhao, Lili

University of Michigan
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Lili Zhao
Favorite
Zhou, Yifan

MD Anderson Cancer Center
Paper 88 - A NOVEL CD103+ CDC1 DENDRITIC CELL VACCINE FOR OSTEOSARCOMA
Yifan Zhou
Favorite
Zhu, Shirley

Stanford University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Shirley Zhu
Favorite
Ziegler, David

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
David Ziegler
Favorite
Zimmerman, Seth

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Seth Zimmerman
Favorite
Zwaan, Christian Michel

Prinses Maxima Centrum
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Christian Michel Zwaan
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Christian Michel Zwaan
Favorite
Zyczynski, Laurie

University of Michigan
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Laurie Zyczynski
Favorite